Phlebitis and thrombophlebitis (not including DVT)

I9_PHLETHROM

Phlebitis: Inflammation of a vein.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I80 Hospital discharge: ICD-9 — 4519X\|4518X Hospital discharge: ICD-8 — 451 Hospital discharge: excluded ICD-10 — I80.20#, I80.29#, I80.3# Hospital discharge: excluded ICD-8 — 4510 Cause of death: ICD-10 — I80 Cause of death: ICD-9 — 4519X\|4518X Cause of death: ICD-8 — 451 Cause of death: excluded ICD-10 — I80.20#, I80.29#, I80.3# Cause of death: excluded ICD-8 — 4510 2 out of 7 registries used, show all original rules.	10726
4. Check minimum number of events None	10726
5. Include endpoints None	10726
6. Filter based on genotype QC (FinnGen only)	10405

Control definitions (FinnGen only)

Control exclude: I9_DISVEINLYMPH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I80-I89
Name in latin: Phlebitis et thrombophlebitis

NAME	I9_PHLETHROM
CONTROL_EXCLUDE	I9_DISVEINLYMPH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I80
HD_ICD_9	4519X\|4518X
HD_ICD_8	451
HD_ICD_10_EXCL	I802\|I803
HD_ICD_9_EXCL
HD_ICD_8_EXCL	4510
COD_MAINONLY
COD_ICD_10	I80
COD_ICD_9	4519X\|4518X
COD_ICD_8	451
COD_ICD_10_EXCL	I802\|I803
COD_ICD_9_EXCL
COD_ICD_8_EXCL	4510
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Phlebitis and thrombophlebitis (not including DVT) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	71773	42313	29016
Only index persons	64610	38528	26082
Unadjusted period prevalence (%)
Whole population	1.05	1.21	0.81
Only index persons	1.25	1.42	1.00
Median age at first event (years)
Whole population	61.90	62.83	60.49
Only index persons	60.82	61.61	59.64

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10405	6171	4234
Unadjusted period prevalence (%)	2.09	2.19	1.94
Median age at first event (years)	59.17	57.49	61.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10726: Matched controls
107260

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

21.9

307.7

1840

1006

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

51.2

307.7

600

124

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

24.4

307.7

1331

618

I83

ICD-10 Finland

Varicose veins of lower extremities

9.8

307.7

416

439

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

38.8

307.7

1964

616

D68.8

ICD-10 Finland

Other specified coagulation defects

16.1

307.7

370

237

K95

ICPC

Varicose veins of leg

14.4

307.7

329

235

B01AF01

ATC

rivaroxaban; oral

3.4

307.7

2099

7215

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

66.9

307.7

925

151

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

12.6

307.7

614

513

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

8.4

307.7

937

1211

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

271.1

307.7

1953

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

350.5

307.7

2333

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

561.0

307.7

484

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

6.6

307.7

1388

2364

B01AB04

ATC

dalteparin; parenteral

4.7

307.7

1029

2386

K94

ICPC

Phlebitis/thrombophlebitis

33.4

307.7

806

260

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

64.3

307.7

1435

257

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

88.1

307.7

792

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

278.0

307.7

5367

385

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

3868.5

307.7

1080

A46

ICD-10 Finland

Erysipelas

2.8

307.7

2056

8286

B01AB05

ATC

enoxaparin; parenteral

6.2

307.7

6514

21471

B01AF02

ATC

apixaban; oral

2.9

307.7

1837

7170

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

18.3

307.7

2667

1906

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

785.3

307.7

2287

B01AA03

ATC

warfarin; systemic

4.8

307.7

3732

10811

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

307.7

650

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

1019.0

307.7

487

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

67.4

307.7

805

129

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

13.9

307.7

4270

4864

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

28.5

307.7

422

154

M79.6

ICD-10 Finland

Pain in limb

2.4

307.7

5356

31364

R60.0

ICD-10 Finland

Localized oedema

3.3

307.7

1973

6841

B01AB10

ATC

tinzaparin; parenteral

3.2

307.7

1593

5557

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

34.1

307.7

699

219

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

307.7

647

PHD99

NOMESCO Finland

Resection of other vein

1407.4

307.7

1353

PHD76

NOMESCO Finland

Resection of long saphenous vein

1347.8

307.7

868

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

2781.3

291.7

281

PHT99

NOMESCO Finland

Injection of therapeutic or sclerosing agent into other vein

134.5

290.2

146

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

285.0

1201

3971

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

249.6

5305

35578

L14

ICPC

Leg/thigh symptom/complaint

3.0

225.0

1114

4024

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

549.1

218.0

216

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

209.4

1689

7763

C03CA01

ATC

furosemide; systemic

2.0

206.1

3409

20654

L17

ICPC

Foot/toe symptom/complaint

2.0

203.8

3296

19802

5612

FHL

Local excisions and / or perforations of relapsing varicose veins

1012.6

203.7

199

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

5.6

201.2

390

718

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

195.4

187

PHM79

NOMESCO Finland

Endovenous obliteration of v.saphena anterior

+∞

186.0

178

K93

ICPC

Pulmonary embolism

8.8

183.3

231

267

N02AA05

ATC

oxycodone; systemic

2.1

183.0

2104

11128

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

31.1

175.0

114

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

8.6

173.6

223

264

PH2AE, ,

SPAT

5.6

164.8

319

586

N02AX02

ATC

tramadol; systemic, rectal

1.7

162.3

4719

33367

A08

ICPC

Swelling

3.2

160.5

683

2249

I87.0

ICD-10 Finland

Postthrombotic syndrome

522.3

156.2

155

N02BE01

ATC

paracetamol; systemic, rectal

2.3

155.9

9601

84339

J01DB01

ATC

cefalexin; oral

2.0

150.5

8831

75451

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

150.3

1338

6355

A02BC02

ATC

pantoprazole; systemic

1.8

150.0

7352

59436

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

149.9

733

2612

R06.0

ICD-10 Finland

Dyspnoea

1.8

144.8

2950

18694

S97

ICPC

Chronic ulcer skin

2.9

139.5

713

2601

PHD77

NOMESCO Finland

Resection of short saphenous vein

1307.5

132.6

129

I26

ICD-10 Finland

Pulmonary embolism

7.4

132.1

193

266

JN4BD

NOMESCO Finland

Extensive body CT

2.2

128.2

1248

6123

H02AB06

ATC

prednisolone; systemic

1.6

125.7

5044

37933

I82

ICD-10 Finland

Other venous embolism and thrombosis

21.3

124.5

J01FF01

ATC

clindamycin; systemic

1.7

122.6

2866

18735

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

120.0

4396

32213

R50.9

ICD-10 Finland

Fever, unspecified

1.9

117.6

1623

9026

PHD78

NOMESCO Finland

Resection of communicating veins of lower leg and thigh

584.6

117.3

116

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

116.9

1439

7693

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

116.8

3782

26840

J01MA12

ATC

levofloxacin; systemic

1.8

115.7

2011

12035

H02AB02

ATC

dexamethasone; systemic

2.0

114.8

1333

6975

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

114.6

2431

15421

B01AX05

ATC

fondaparinux; parenteral

7.3

112.7

165

228

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

111.4

2344

14818

ZX120

NOMESCO Finland

Intravenous

2.1

111.3

1105

5448

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

110.3

3057

20796

S18

ICPC

Laceration/cut

1.6

110.1

4680

35297

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

108.0

2607

17090

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

107.6

1702

9870

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

107.0

441

1420

Z3231

NOMESCO Finland

Registered nurse

1.7

106.1

2877

19427

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

105.8

420

1322

PHB76

NOMESCO Finland

Ligature of long saphenous vein

1028.7

104.4

102

TPH10

NOMESCO Finland

Sclerotherapy of varicose veins

216.1

103.7

107

K99

ICPC

Cardiovascular disease other

3.5

102.3

360

1050

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

+∞

101.2

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

12.7

100.7

PHB78

NOMESCO Finland

Ligature of perforating veins of lower extremity

+∞

100.1

WX002

NOMESCO Finland

Sedation and analgesia

1.7

99.3

2035

12718

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

99.0

687

2908

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

98.8

3522

25326

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

97.1

1463

8333

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

95.9

218

461

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

95.6

4578

35088

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

95.0

1729

10429

N03AX16

ATC

[U] pregabalin

1.7

94.5

2449

16267

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

94.0

1782

10875

ZXA00

NOMESCO Finland

Right side

1.6

93.1

2722

18622

PHL99

NOMESCO Finland

Ultrasound guided foam sclerotherapy of other vein

313.1

93.0

JN4AD

NOMESCO Finland

Body CT examination

2.0

92.6

1108

5836

Z3226

NOMESCO Finland

Physiotherapist

1.7

92.4

1909

11931

PHL76

NOMESCO Finland

Ultrasound guided foam sclerotherapy of long saphenous vein

456.7

91.4

ZXA05

NOMESCO Finland

Left side

1.6

90.2

2529

17103

L28

ICPC

Limited function/disability (L)

1.7

89.4

1836

11443

R4110

NOMESCO Finland

Physiotherapy

1.6

88.3

2847

19895

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

86.5

546

2208

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

30.2

86.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

86.4

2621

18039

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

85.4

2886

20358

R52.9

ICD-10 Finland

Pain, unspecified

2.0

85.1

1046

5554

K07

ICPC

Swollen ankles/oedema

2.6

85.0

521

2077

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

7.5

84.9

122

165

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

17.5

83.4

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

5.2

83.0

172

336

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

82.5

1203

6759

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

82.1

1077

5844

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

81.8

3113

22504

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

81.8

1664

10319

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

81.5

1021

5454

L03AA13

ATC

pegfilgrastim; parenteral

2.5

81.3

529

2169

J01MA02

ATC

ciprofloxacin; systemic

1.5

80.1

3901

29673

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.5

79.9

531

2199

J01DA01

ATC

[U] cefalexin

1.5

79.9

6228

51951

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

78.6

2146

14351

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

78.1

1884

12213

K06

ICPC

Prominent veins

23.5

77.8

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

13.4

77.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

77.4

3566

26770

L04AA06

ATC

mycophenolic acid; systemic

3.7

76.8

246

674

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

76.7

1103

6161

A04AA01

ATC

ondansetron; systemic, rectal

2.0

76.6

882

4571

127

Kela drug reimbursment

Transplant complication

4.2

75.7

205

498

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

75.0

876

4560

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

74.9

1877

12271

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.0

74.6

348

1203

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

73.6

7037

60562

I81

ICD-10 Finland

Portal vein thrombosis

252.0

73.4

AA1AD

NOMESCO Finland

CT of head and brain

1.5

73.0

2700

19311

ZXE00

NOMESCO Finland

One hour or less

1.5

72.8

3810

29248

45199

ICD-8 Finland

Phlebitis and thrombophlebitis, Of other and unspecified sites

+∞

71.9

ZXD05

NOMESCO Finland

Urgent procedure

1.5

71.6

2986

21886

UJF32

NOMESCO Finland

Coloscopy

1.5

71.3

2605

18563

SPAT1229

SPAT

Assessment of need for aid

2.0

70.9

819

4244

R53

ICD-10 Finland

Malaise and fatigue

1.6

70.8

2359

16470

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

70.0

1331

8073

L15

ICPC

Knee symptom/complaint

1.6

68.9

2283

15906

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

68.1

648

3124

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

68.1

1610

10348

PHG76

NOMESCO Finland

Intraluminal laser vein occlusion of long saphenous vein

+∞

67.8

E0000UV, ,

ATC

1.4

67.4

3985

31181

R51.80

ICD-10 Finland

Headache

1.7

67.4

1473

9275

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

67.1

320

1119

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

228.1

66.3

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

66.0

1804

12007

D68.9

ICD-10 Finland

Coagulation defect, unspecified

9.8

66.0

S76

ICPC

Skin infection other

2.2

65.2

549

2520

M54.5

ICD-10 Finland

Low back pain

1.4

64.4

3461

26543

5613

FHL

Conjunctival occlusion

221.3

64.2

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

64.2

1773

11823

Z71.8

ICD-10 Finland

Other specified counselling

1.5

63.9

2931

21797

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

63.5

3486

26822

PHD79, ,

NOMESCO Finland

319.0

63.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

62.9

5035

41411

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

62.6

1812

12208

Z94.0

ICD-10 Finland

Kidney transplant status

4.5

62.2

153

345

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

62.2

3938

31068

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

62.0

1504

9710

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.8

61.2

320

1176

SPAT1263

SPAT

Sampling

1.4

61.0

4010

31813

S29

ICPC

Skin symptom/complaint other

1.6

61.0

1822

12358

Z2221

NOMESCO Finland

Medical doctor

1.5

60.5

2637

19380

SPAT1254

SPAT

Administration of medicine

1.6

59.9

1407

9004

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

59.2

1473

9562

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

59.1

350

1370

R03AC02

ATC

salbutamol; inhalant

1.4

59.1

5327

44515

O22.0

ICD-10 Finland

Varicose veins of lower extremity in pregnancy

25.7

58.8

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

58.0

1175

7230

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

57.9

642

3273

Z2446

NOMESCO Finland

Social worker

2.0

57.8

629

3185

M25.5

ICD-10 Finland

Pain in joint

1.4

57.8

3035

23074

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

57.7

2819

21141

ZXA10

NOMESCO Finland

Bilateral

1.6

57.5

1750

11903

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.5

57.2

375

1541

WZC30

NOMESCO Finland

Teaching

1.6

56.4

1544

10245

X58

ICD-10 Finland

Exposure to other specified factors

1.6

56.3

1314

8385

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

55.8

1365

8813

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.3

55.7

432

1914

A01

ICPC

Pain general/multiple sites

1.8

55.5

896

5166

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.3

55.4

455

2065

P01AB01

ATC

metronidazole; oral, rectal

1.4

55.3

3854

30736

E66.8

ICD-10 Finland

Other obesity

2.1

55.3

532

2573

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

55.0

896

5179

M04AA01

ATC

allopurinol; systemic

1.7

54.8

1232

7784

SPAT1211

SPAT

Application of soft bandage

1.8

54.2

830

4709

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

54.0

4387

35845

WW500

NOMESCO Finland

Blood transfusion

2.3

53.0

419

1871

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.7

52.7

123

266

H02AB07

ATC

prednisone; oral

1.6

52.6

1334

8682

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

52.6

1911

13483

R02

ICPC

Shortness of breath/dyspnoea

1.6

52.4

1235

7894

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

52.3

606

3136

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.4

52.3

131

300

J01MA14

ATC

moxifloxacin; systemic

1.8

52.2

882

5152

45198

ICD-8 Finland

Phlebitis and thrombophlebitis, Alia definita

+∞

52.1

J01AA02

ATC

doxycycline; systemic

1.4

52.0

7857

70736

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

51.8

1660

11396

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

51.4

349

1458

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

51.3

1643

11278

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

51.1

588

3035

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

50.9

244

856

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

50.9

1258

8132

M79.1

ICD-10 Finland

Myalgia

1.6

50.8

1330

8716

L16

ICPC

Ankle symptom/complaint

1.7

50.6

1044

6443

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

50.5

3635

29030

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

50.3

459

2174

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

50.1

359

1537

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

+∞

50.0

A04AA02

ATC

granisetron; systemic, transdermal

1.9

50.0

652

3512

A02BC05

ATC

esomeprazole; systemic

1.4

49.9

3963

32132

A06AD11

ATC

lactulose; oral

1.6

49.9

1380

9159

L03

ICPC

Low back symptom/complaint

1.4

49.9

2555

19238

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

49.6

1274

8309

K29

ICPC

Cardiovascular sympt/complt other

2.2

49.4

441

2071

N30.0

ICD-10 Finland

Acute cystitis

1.5

49.2

1525

10382

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.6

49.1

160

444

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

7.0

49.0

106

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

49.0

2071

15037

TK800

NOMESCO Finland

Hemodialysis

2.9

48.6

234

823

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

48.4

1154

7388

UKC02

NOMESCO Finland

Cystoscopy

1.6

48.4

1464

9912

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

48.1

2127

15568

WX892

NOMESCO Finland

Monitored bed care

1.8

47.9

731

4137

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.7

47.8

267

1016

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

47.7

651

3558

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

47.4

437

2077

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

46.8

1141

7341

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

46.7

922

5619

L03AA02

ATC

filgrastim; parenteral

2.4

46.2

320

1349

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

46.1

233

842

WX320

NOMESCO Finland

Spinalanesthesy

1.4

46.0

2245

16716

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

19.0

45.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

45.7

432

2074

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.9

45.5

202

J01CA04

ATC

amoxicillin; systemic

1.4

45.4

8037

73190

PHB99

NOMESCO Finland

Ligature of other vein

59.2

45.3

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

45.2

2642

20300

SPAT1255

SPAT

Intravenous administration of medicine

1.9

45.0

646

3588

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

44.9

588

3171

R07.3

ICD-10 Finland

Other chest pain

1.7

44.8

957

5952

O22.2

ICD-10 Finland

Superficial thrombophlebitis in pregnancy

58.0

44.3

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.9

44.1

203

697

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.7

44.0

242

914

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

43.7

424

2055

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

43.7

2653

20492

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

7.1

43.5

130

Kela drug reimbursment

Malignant tumour

1.7

43.4

835

5049

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

43.2

665

3771

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

43.1

543

2889

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

43.0

2065

15309

A28

ICPC

Limited function/disability NOS

1.5

42.9

1549

10868

J01FA06

ATC

roxithromycin; oral

1.3

42.8

3768

30831

M10.9

ICD-10 Finland

Gout, unspecified

1.8

42.4

627

3513

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

42.4

1222

8168

SPAT1216

SPAT

Assessment of functional ability

1.5

42.3

1428

9880

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

42.2

1806

13099

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.2

42.1

111

265

PH1AT

NOMESCO Finland

Endovascular extension of superior vena cava and of arteries of upper extremity

113.0

41.7

K28

ICPC

Limited function/disability (K)

2.7

41.6

224

837

I87.9

ICD-10 Finland

Disorder of vein, unspecified

10.3

41.3

H02AB04

ATC

methylprednisolone; systemic

1.5

41.2

1344

9225

M03BX02

ATC

tizanidine; oral

1.3

41.2

5954

52166

Z51.5

ICD-10 Finland

Palliative care

1.7

41.1

733

4338

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.7

41.1

128

345

L01BC06

ATC

capecitabine; oral

2.1

41.0

402

1957

G47.3

ICD-10 Finland

Sleep apnoea

1.4

40.8

2064

15424

S80.0

ICD-10 Finland

Contusion of knee

1.8

40.7

658

3785

SPAT1260

SPAT

Consultation of another employee

1.5

40.7

1605

11449

L04AD02

ATC

tacrolimus; systemic

3.9

40.7

118

302

4518X

ICD-9 Finland

Phlebitis and thrombophlebitis, Of other sites

+∞

40.6

A04AA55

ATC

palonosetron, combinations; systemic

2.2

40.5

363

1707

R31

ICD-10 Finland

Unspecified haematuria

1.6

40.4

901

5660

R06AE07

ATC

cetirizine; oral

1.3

40.1

4078

33978

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

40.1

970

6218

A11CC03

ATC

alfacalcidol; systemic

2.6

39.8

242

960

N03AX12

ATC

[U] gabapentin; oral

1.5

39.7

1501

10614

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

39.7

804

4927

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

+∞

39.6

XW000

NOMESCO Finland

Bone marrow biopsy

2.1

39.5

394

1930

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

39.3

785

4791

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

39.1

626

3591

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.6

39.1

1011

6584

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

5.6

39.1

130

K02.1

ICD-10 Finland

Caries of dentine

1.3

39.1

5415

47018

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

38.9

246

995

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

38.8

2112

15968

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

38.7

244

985

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

38.7

1700

12372

S06.0

ICD-10 Finland

Concussion

1.6

38.6

963

6218

M02AA07

ATC

piroxicam; topical

1.3

38.4

3383

27572

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

38.4

1181

7999

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.1

38.2

106

263

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

37.9

2505

19538

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

37.8

802

4974

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.9

37.6

472

2508

4540A

ICD-9 Finland

Varicose veins of lower extremities, With ulcer

+∞

37.5

A02BC01

ATC

omeprazole; systemic

1.4

37.4

2527

19772

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

36.8

3546

29226

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

36.6

673

4017

28920

ICD-8 Finland

Other disease of blood and blood-forming organs, Nonspecific mesenteric lymphadenitis

+∞

36.5

S01

ICPC

Pain/tenderness of skin

2.0

36.4

416

2140

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

3.2

36.4

146

463

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

36.4

979

6431

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.8

36.4

169

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

36.3

195

728

B03XA02

ATC

darbepoetin alfa; parenteral

2.6

36.2

210

815

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

36.1

465

2491

M01AE02

ATC

naproxen; oral, rectal

1.3

36.0

5271

45890

ZXC10

NOMESCO Finland

Use of laser

2.7

35.8

201

767

RD210, ,

NOMESCO Finland

2.9

35.8

174

616

L04AX01

ATC

azathioprine; systemic

2.0

35.5

392

1993

D07AC01

ATC

betamethasone; topical

1.3

35.5

3275

26796

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

35.5

846

5399

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

35.2

322

1527

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

7.5

35.2

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

35.0

920

6009

J01CF05

ATC

flucloxacillin; systemic

1.8

34.8

527

2972

Z00.0

ICD-10 Finland

General medical examination

1.4

34.7

1702

12608

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.6

34.7

203

791

R42

ICD-10 Finland

Dizziness and giddiness

1.4

34.7

2105

16166

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

34.6

292

1340

R5110, ,

SPAT

1.7

34.6

596

3491

R11

ICD-10 Finland

Nausea and vomiting

1.6

34.5

765

4793

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.9

34.4

160

553

C03DA01

ATC

spironolactone; oral

1.5

34.2

1028

6920

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

33.9

1143

7882

N05BA04

ATC

oxazepam; oral

1.4

33.7

2367

18583

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

33.6

1057

7182

G44.2

ICD-10 Finland

Tension-type headache

1.5

33.5

1197

8349

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

33.4

2034

15613

P19

ICPC

Drug abuse

4.2

33.4

206

ZXC08

NOMESCO Finland

Other ablative laser

+∞

33.3

4519X

ICD-9 Finland

Phlebitis and thrombophlebitis, Of unspecified site

+∞

33.3

M01AB05

ATC

diclofenac; systemic, rectal

1.3

33.1

6381

57239

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

33.0

6402

57459

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

33.0

991

6667

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

33.0

979

6569

L04AD01

ATC

ciclosporin; systemic

2.7

32.9

183

696

A12AA04

ATC

calcium carbonate; oral

2.9

32.6

153

532

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

32.3

432

2343

V03AE02

ATC

sevelamer; oral

4.9

32.2

143

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

32.1

3750

31560

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

32.0

798

5143

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

32.0

1052

7212

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

31.9

662

4077

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

31.9

326

1613

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

72.4

31.8

A03

ICPC

Fever

1.4

31.8

1356

9781

S06

ICPC

Rash localized

1.8

31.7

494

2810

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

31.7

997

6771

C07AB07

ATC

bisoprolol; oral

1.3

31.5

4538

39178

WX402

NOMESCO Finland

General anaesthesia

1.4

31.5

1871

14293

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

31.4

3379

28113

J01DA09

ATC

[U] cefadroxil

1.3

31.3

2348

18589

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

31.2

2236

17577

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

31.1

1117

7797

R52.2

ICD-10 Finland

Other chronic pain

2.0

31.0

332

1671

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

30.8

736

4695

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

30.8

521

3035

W19

ICD-10 Finland

Unspecified fall

1.6

30.8

853

5633

J01EA01

ATC

trimethoprim; systemic

1.3

30.7

2357

18711

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

30.7

1225

8726

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

30.7

975

6635

I82.21

ICD-10 Finland

Emboli and thrombosis in the inferior vena cava

110.4

30.7

PH2ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance

110.4

30.7

S10

ICPC

Boil/carbuncle

1.8

30.6

501

2890

R52.0

ICD-10 Finland

Acute pain

2.1

30.6

298

1447

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

30.6

750

4813

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

30.6

1718

12995

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

30.5

396

2129

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.3

30.2

111

334

SPAT1301

SPAT

No procedures

1.3

30.2

2777

22600

V03AE01

ATC

polystyrene sulfonate; oral

3.0

30.2

136

462

45400

ICD-8 Finland

Varicose veins of lower extremities, With ulcer

+∞

30.2

A99

ICPC

Disease/condition unspecnature/site

1.6

30.2

813

5334

N18.0

ICD-10 Finland

End-stage renal disease

3.2

30.1

116

360

I89.1

ICD-10 Finland

Lymphangitis

7.2

30.0

SPAT1153

SPAT

Removal of sutures

1.3

30.0

2825

23061

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

30.0

404

2196

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

29.9

934

6330

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.2

29.8

118

372

Z72.2

ICD-10 Finland

Drug use

5.0

29.8

126

5619

FHL

Other measure in this category

82.8

29.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

29.7

616

3794

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

7.3

29.6

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

29.6

621

3835

R05

ICPC

Cough

1.3

29.6

2084

16325

L13

ICPC

Hip symptom/complaint

1.4

29.6

1594

11972

R74

ICPC

Upper respiratory infection acute

1.3

29.5

2607

21089

K78

ICPC

Atrial fibrillation/flutter

1.6

29.5

648

4048

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

29.4

393

2131

J02AC01

ATC

fluconazole; systemic

1.3

29.4

3552

29928

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.6

29.3

176

696

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

29.2

307

1534

PHM78

NOMESCO Finland

Endovenous obliteration of perforating veins of lower extremity

+∞

29.2

L12

ICPC

Hand/finger symptom/complaint

1.4

29.2

1386

10186

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

29.1

553

3328

S22.3

ICD-10 Finland

Fracture of rib

1.7

28.9

608

3756

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.7

28.9

601

3703

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

27.9

28.8

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.4

28.8

200

846

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

28.8

496

2905

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.0

28.7

316

1605

RS221, ,

NOMESCO Finland

2.8

28.7

141

503

RS222, ,

NOMESCO Finland

3.0

28.4

124

414

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.1

28.3

288

1422

A04AD12

ATC

aprepitant; systemic

2.3

28.3

205

883

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

28.3

586

3606

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

28.2

163

632

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

28.2

4230

36527

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

+∞

28.1

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

28.1

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

28.1

677

4325

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

28.0

439

2501

L90

ICPC

Osteoarthrosis of knee

1.7

27.9

571

3503

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

27.8

1630

12399

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

282.3

27.8

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.1

27.7

279

1373

L08

ICPC

Shoulder symptom/complaint

1.3

27.6

1908

14883

L04AA01

ATC

[U] ciclosporin

2.8

27.4

136

488

WW200

NOMESCO Finland

Immunization

2.1

27.4

248

1172

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

27.4

743

4881

HA1AA

NOMESCO Finland

X-ray mammography

1.6

27.3

675

4338

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

27.3

471

2758

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

27.3

354

1901

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

27.3

2340

18818

128

Kela drug reimbursment

Cancers of female genital organs

2.5

27.3

172

696

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

27.3

504

3009

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

27.2

715

4664

R03BA05

ATC

fluticasone; inhalant

1.4

27.1

1563

11852

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

26.9

706

4604

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

4.7

26.8

130

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

26.8

294

1493

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

26.7

672

4337

SFA10

NOMESCO Finland

One-surface restoration

1.2

26.7

4944

43634

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

26.7

716

4692

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

26.6

848

5767

J01FA10

ATC

azithromycin; systemic

1.2

26.6

5222

46383

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

26.5

498

2987

D09AB01

ATC

zinc bandage without supplements; topical

2.5

26.1

165

669

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

26.1

653

4211

A04

ICPC

Weakness/tiredness general

1.4

26.1

1216

8897

N02BF02

ATC

pregabalin; oral

1.7

26.0

506

3062

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.9

26.0

339

1825

M01AH05

ATC

etoricoxib; oral

1.2

25.9

5817

52367

R55

ICD-10 Finland

Syncope and collapse

1.5

25.9

939

6557

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

25.8

229

1074

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

25.8

331

1772

R4120

NOMESCO Finland

Occupational therapy

1.6

25.8

559

3480

A29

ICPC

General symptom/complaint other

1.4

25.8

1073

7690

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

25.7

226

1056

N06AX11

ATC

mirtazapine; oral

1.3

25.7

3064

25675

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

25.7

870

5992

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

25.7

5057

44860

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

25.6

257

1263

U02

ICPC

Urinary frequency/urgency

1.4

25.6

1195

8740

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.5

25.6

159

639

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.5

25.6

135

L02BG06

ATC

exemestane; oral

2.4

25.6

174

730

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

25.5

1139

8268

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.0

25.4

182

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.4

25.4

177

751

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

5.8

25.3

R4190

NOMESCO Finland

Nutritional therapy

1.9

25.3

307

1614

J20

ICD-10 Finland

Acute bronchitis

1.5

25.3

870

6011

Z00.8

ICD-10 Finland

Other general examinations

1.6

25.2

647

4194

A02BC03

ATC

lansoprazole; oral

1.3

25.2

2579

21197

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.3

25.1

186

810

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

25.0

673

4411

D07AC13

ATC

mometasone; topical

1.3

25.0

2516

20632

J01FA09

ATC

clarithromycin; systemic

1.3

25.0

2754

22841

R35

ICD-10 Finland

Polyuria

1.6

25.0

555

3476

U07

ICPC

Urine symptom/complaint other

1.6

24.9

626

4038

E000001, ,

ATC

1.3

24.9

1649

12761

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

24.9

769

5194

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

24.9

1529

11698

JN4CD

NOMESCO Finland

Very extensive body CT

1.9

24.8

324

1745

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

70.0

24.8

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

24.8

406

2344

PH1ST

NOMESCO Finland

Endovascular thrombolysis of upper extremity veins with radiological guidance

250.8

24.7

ZX108

NOMESCO Finland

Inhalation

3.6

24.6

218

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

24.6

255

1269

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.0

24.6

105

347

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

24.5

489

2979

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

24.5

343

1889

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

24.5

525

3259

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.2

24.4

292

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

5.8

24.4

3AC01, ,

NOMESCO Finland

3.2

24.3

313

N05CF01

ATC

zopiclone; oral

1.3

24.3

2914

24401

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

24.3

6664

61086

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.4

24.2

159

656

M01AH01

ATC

celecoxib; oral

1.3

24.2

1563

12044

N19

ICD-10 Finland

Unspecified kidney failure

1.9

24.2

300

1588

R03BB04

ATC

tiotropium bromide; inhalant

1.5

24.2

847

5869

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.2

24.2

193

868

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

24.1

533

3334

J46

ICD-10 Finland

Status asthmaticus

2.0

24.1

251

1252

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

24.0

335

1843

PHL77

NOMESCO Finland

Ultrasound guided foam sclerotherapy of short saphenous vein

+∞

24.0

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

23.9

753

5107

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.8

23.8

115

407

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

23.8

2552

21068

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

23.8

375

2140

115

Kela drug reimbursment

Breast cancer

1.5

23.8

741

5015

K92.1

ICD-10 Finland

Melaena

1.7

23.7

438

2616

N05BA01

ATC

diazepam; systemic, rectal

1.4

23.7

1106

8087

PHB77

NOMESCO Finland

Ligature of short saphenous vein

240.5

23.6

I82.1

ICD-10 Finland

Thrombophlebitis migrans

86.9

23.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

23.6

851

5931

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

23.5

593

3830

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.1

23.4

215

1023

SFA30

NOMESCO Finland

Three-surface restoration

1.2

23.4

3791

32814

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

23.3

671

4462

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

23.2

499

3100

Z50.1

ICD-10 Finland

Other physical therapy

1.7

23.2

454

2753

ZX112

NOMESCO Finland

Subcutaneous

2.2

23.2

197

909

K60

ICPC

Cardiovascular, Result test/procedure

3.5

23.2

232

WX290

NOMESCO Finland

Other blockage of nerve

1.2

23.2

3981

34667

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

23.1

669

4457

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

23.1

372

2138

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

22.9

1234

9242

XKD00

NOMESCO Finland

Uroflowmetry

1.4

22.9

1249

9373

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

22.8

619

4063

J45

ICD-10 Finland

Asthma

1.5

22.8

860

6046

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

22.8

632

4170

L04AX03

ATC

methotrexate; systemic

1.5

22.7

811

5641

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

22.7

188

859

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.8

22.7

313

1717

RS220, ,

NOMESCO Finland

2.7

22.6

119

441

D07AB08

ATC

desonide; topical

1.5

22.6

877

6197

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

22.6

215

1037

A06AH03

ATC

naloxegol; oral

2.6

22.5

131

511

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

7.0

22.4

R03DC03

ATC

montelukast; oral

1.4

22.4

1389

10628

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

22.4

1125

8324

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

22.4

291

1566

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

4.6

22.3

113

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

22.3

477

2959

M01AX17

ATC

nimesulide; oral

1.3

22.3

2094

16982

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.6

22.3

129

502

WX610

NOMESCO Finland

Patient controlled analgesia

3.6

22.2

205

L02

ICPC

Back symptom/complaint

1.5

22.1

801

5589

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

22.0

244

1244

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

22.0

1773

14087

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

22.0

2175

17750

L29

ICPC

Musculoskeletal sympt/complt other

1.5

22.0

712

4854

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

22.0

211

1021

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.6

22.0

530

3387

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

21.9

452

2778

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

21.9

836

5890

WX882

NOMESCO Finland

High dependency care

2.0

21.9

224

1111

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.6

21.8

121

461

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

22.2

21.6

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

7.4

21.6

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

21.6

216

1062

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

21.6

299

1642

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.9

21.5

291

1586

Z01.2

ICD-10 Finland

Dental examination

1.2

21.5

3930

34361

M01AX05

ATC

glucosamine; oral

1.3

21.5

1646

12984

NF3AA

NOMESCO Finland

Femur X-ray examination

2.2

21.4

180

827

R96

ICPC

Asthma

1.5

21.4

796

5579

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

21.4

5991

54653

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.0

21.4

151

T82

ICPC

Obesity

1.8

21.2

316

1775

G04CA02

ATC

tamsulosin; oral

1.3

21.2

1826

14636

N06AX16

ATC

venlafaxine; oral

1.4

21.1

1152

8638

N05AH04

ATC

quetiapine; oral

1.3

21.1

1430

11085

SPAT1234

SPAT

Support of social functional capacity

1.7

21.1

429

2629

L60.0

ICD-10 Finland

Ingrowing nail

1.7

21.0

374

2213

J01CA08

ATC

pivmecillinam; oral

1.2

20.9

3577

31045

I82.0

ICD-10 Finland

Budd-Chiari syndrome

+∞

20.8

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

20.7

681

4660

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

20.6

2292

18953

M05BX04

ATC

denosumab; parenteral

1.6

20.6

505

3239

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

20.6

881

6337

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

20.6

318

EBA00

NOMESCO Finland

Extraction of tooth

1.2

20.5

3007

25654

S21

ICPC

Skin texture symptom/complaint

1.4

20.5

1150

8656

SPAT1310

SPAT

Counselling related to known health issue

1.2

20.5

2687

22644

D11

ICPC

Diarrhoea

1.4

20.5

913

6613

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

20.5

223

1131

R03AC03

ATC

terbutaline; inhalant

1.4

20.4

1153

8688

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

20.4

693

4770

A07AA02

ATC

nystatin; oral

1.6

20.4

493

3151

N06AB04

ATC

citalopram; systemic

1.3

20.4

1819

14635

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

6.7

20.4

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

20.2

332

1920

R07.1

ICD-10 Finland

Chest pain on breathing

2.4

20.2

135

563

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.3

20.2

158

706

R03BA02

ATC

budesonide; inhalant

1.3

20.2

1494

11722

R10.0

ICD-10 Finland

Acute abdomen

1.9

20.1

265

1434

L52

ICD-10 Finland

Erythema nodosum

3.5

20.1

200

SPAT1262

SPAT

Handing over of treatment supplies

1.3

20.1

1469

11507

I87.8

ICD-10 Finland

Other specified disorders of veins

16.0

20.0

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

20.0

1074

8027

D01

ICPC

Abdominal pain/cramps general

1.4

20.0

911

6627

XQ800

NOMESCO Finland

Prick test

1.5

19.9

568

3771

A01AB09

ATC

miconazole; local oral

1.5

19.9

720

5019

PHG77

NOMESCO Finland

Intraluminal laser vein occlusion of short saphenous vein

+∞

19.8

PH1UT

NOMESCO Finland

Removal of thrombosis from veins of upper extremity of from upper vena cava

+∞

19.8

O87.0

ICD-10 Finland

Superficial thrombophlebitis in the puerperium

+∞

19.8

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.5

19.8

126

514

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

19.8

348

2052

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.2

19.7

125

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

19.7

285

1587

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

19.7

922

6737

I87.1

ICD-10 Finland

Compression of vein

73.6

19.7

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

5.0

19.7

R33

ICD-10 Finland

Retention of urine

1.5

19.6

608

4108

N06AX21

ATC

duloxetine; oral

1.4

19.6

963

7094

PH9ST

NOMESCO Finland

Intravenous thrombolysis of other vein

200.4

19.6

Z01.7

ICD-10 Finland

Laboratory examination

1.3

19.5

1205

9206

M54.8

ICD-10 Finland

Other dorsalgia

1.7

19.5

365

2189

A97

ICPC

No disease

1.3

19.5

1450

11381

S04

ICPC

Lump/swelling localized

1.4

19.4

819

5874

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

19.4

542

3581

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

19.4

585

3930

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

19.4

651

4471

TK810

NOMESCO Finland

Hemofiltration

3.5

19.4

195

SPAT1167

SPAT

Insertion of urinary catheter

1.9

19.3

255

1380

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

3.7

19.3

158

M05BA04

ATC

alendronic acid; oral

1.5

19.3

729

5124

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

19.3

782

5570

SPAT1281

SPAT

Other administrative function

1.5

19.2

621

4232

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

19.2

643

4414

SPAT1172

SPAT

Guidance concerning hydration

2.0

19.1

194

960

V03AE03

ATC

lanthanum carbonate; oral

4.4

19.1

107

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.3

19.1

146

646

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

19.1

956

7063

A02BA02

ATC

ranitidine; systemic

1.3

19.1

1650

13213

-1, ,

NOMESCO Finland

1.2

19.0

2713

23041

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

19.0

240

1280

R01AD09

ATC

mometasone; nasal

1.2

19.0

3987

35213

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

19.0

2360

19744

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.3

19.0

139

604

U71

ICPC

Cystitis/urinary infection other

1.5

18.9

523

3447

R21

ICPC

Throat symptom/complaint

1.3

18.9

1558

12397

I50.0

ICD-10 Finland

Congestive heart failure

1.5

18.9

563

3774

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.1

18.9

125

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

18.8

508

3332

N03AX09

ATC

lamotrigine; oral

1.7

18.8

362

2188

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

18.8

763

5436

S11

ICPC

Skin infection post-traumatic

2.5

18.7

117

473

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

18.7

949

7025

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

18.7

230

1217

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

18.7

983

7322

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.5

18.6

118

481

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

18.5

5675

51876

ZXD35

NOMESCO Finland

Usual procedure

1.8

18.5

272

1523

SPAT1312

SPAT

General health counselling

1.2

18.5

2623

22256

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.3

18.4

135

587

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

4.8

18.4

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

18.4

565

3810

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

1.7

18.3

316

1853

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

18.3

2152

17878

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

18.3

258

1426

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.5

18.3

183

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

18.3

139

614

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

6.6

18.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.0

18.2

275

A11

ICPC

Chest pain NOS

1.5

18.2

670

4685

R01AD08

ATC

fluticasone; nasal

1.2

18.2

2427

20449

WX722

NOMESCO Finland

PEEP

1.7

18.2

369

2260

M76.6

ICD-10 Finland

Achilles tendinitis

1.6

18.2

406

2548

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

6.1

18.1

M54

ICD-10 Finland

Dorsalgia

1.4

18.0

983

7361

B01AE07

ATC

dabigatran etexilate; oral

1.7

18.0

311

1824

N05AH03

ATC

olanzapine; systemic

1.6

18.0

470

3059

B99

ICPC

Blood/lymph/spleen disease other

4.0

18.0

125

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

18.0

913

6759

R05

ICD-10 Finland

Cough

1.3

18.0

1795

14626

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

17.9

2292

19216

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

17.9

318

1880

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.7

17.9

355

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

17.9

274

1554

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.9

17.9

211

1102

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

17.8

1051

7967

D02

ICPC

Abdominal pain epigastric

1.6

17.8

479

3139

R60.1

ICD-10 Finland

Generalized oedema

3.2

17.8

216

S16

ICPC

Bruise/contusion

1.8

17.8

248

1367

H26.3

ICD-10 Finland

Drug-induced cataract

3.5

17.8

177

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

17.7

612

4226

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.4

17.7

117

486

PHK76

NOMESCO Finland

Endovenous radiotherapy of long saphenous vein

+∞

17.7

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

17.7

284

1632

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

17.7

344

2085

SFA20

NOMESCO Finland

Two-surface restoration

1.2

17.6

5222

47497

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

17.6

166

800

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

17.6

217

1150

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

17.6

3318

28949

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

17.6

744

5340

P01BA02

ATC

hydroxychloroquine; oral

1.4

17.5

668

4703

QDB10, ,

SPAT

2.3

17.5

134

594

A07EC02

ATC

mesalazine; oral, rectal

1.6

17.5

415

2644

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.2

17.4

214

K30

ICD-10 Finland

Functional dyspepsia

1.4

17.4

913

6797

ZZA00

NOMESCO Finland

Split skin graft

1.9

17.4

217

1155

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.1

17.4

154

725

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

17.3

466

3054

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

17.3

432

2783

I50

ICD-10 Finland

Heart failure

1.9

17.3

228

1235

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.8

17.3

L09

ICPC

Arm symptom/complaint

1.6

17.3

383

2400

N06AA09

ATC

amitriptyline; systemic

1.4

17.2

796

5800

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

17.2

414

2645

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

17.2

434

2805

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.6

17.1

393

2482

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.2

17.1

143

657

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.2

17.1

206

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

17.1

390

2459

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

14.8

17.1

A41.8

ICD-10 Finland

Other specified sepsis

2.2

17.1

147

684

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

17.0

100

393

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

17.0

490

3259

-50

ICPC

Medication/prescr/renewal

1.7

17.0

328

1985

XG466

NOMESCO Finland

Sleep oxymetry

1.8

16.9

241

1337

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.7

16.9

320

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

16.9

1878

15487

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

6.1

16.8

J01MA01

ATC

ofloxacin; systemic

1.4

16.8

657

4648

A07AA09

ATC

vancomycin; oral

2.3

16.7

122

530

G04BD12

ATC

mirabegron; oral

1.4

16.7

945

7116

L02BG04

ATC

letrozole; oral

1.5

16.7

556

3812

N02BF01

ATC

gabapentin; oral

1.4

16.7

649

4585

R25.2

ICD-10 Finland

Cramp and spasm

1.9

16.7

197

1029

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

16.7

3259

28494

P18

ICPC

Medication abuse

3.3

16.6

180

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.3

16.6

121

526

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

16.5

734

5311

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.0

16.5

178

901

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

16.5

306

1831

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

7.0

16.5

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.6

16.5

397

2537

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

2.8

16.5

291

N07BC02

ATC

methadone; systemic

4.3

16.4

TPX15

NOMESCO Finland

Removal of vascular injection port

3.6

16.4

148

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.4

16.3

951

7192

N05CD07

ATC

temazepam; oral

1.4

16.3

963

7297

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

16.3

187

967

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

16.2

679

4861

R83

ICPC

Respiratory infection other

1.2

16.2

1960

16309

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

16.1

458

3038

L03AA14

ATC

lipegfilgrastim; parenteral

2.0

16.1

166

827

L84

ICD-10 Finland

Corns and callosities

1.7

16.1

276

1617

X57

ICD-10 Finland

Unspecified privation

1.9

16.1

186

965

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

16.1

436

2863

SPAT1240

SPAT

Therapeutic discussion

1.4

16.1

752

5491

JN6AD

NOMESCO Finland

CT of torso and neck

2.2

16.1

138

642

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

16.1

339

2099

M77.4

ICD-10 Finland

Metatarsalgia

1.5

15.9

467

3119

WVA20

NOMESCO Finland

Medicine administration

1.9

15.9

207

1118

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.1

15.8

106

NG2AA

NOMESCO Finland

Patella X-ray examination

1.8

15.8

219

1206

PH1BC

NOMESCO Finland

Extensive ultrasound examination of upper extremity veins

60.1

15.7

D06

ICPC

Abdominal pain localized other

1.4

15.7

665

4773

SPAT1125

SPAT

Stoma care and guidance

2.2

15.6

136

636

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

15.6

305

1851

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

15.5

1862

15469

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

15.5

138

651

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.7

15.5

130

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

15.5

1764

14574

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

15.4

329

2043

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1.5

15.3

466

3137

M01AH02

ATC

rofecoxib; oral

1.3

15.3

1034

7993

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

5.2

15.3

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

15.3

228

1284

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

6.7

15.3

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

15.2

204

1112

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

15.2

196

1055

PH7AC

NOMESCO Finland

Lumbal cavography with X-ray

28.6

15.2

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.8

15.2

208

1142

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

15.1

280

1676

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

15.1

3446

30491

N06AB03

ATC

fluoxetine; oral

1.3

15.1

979

7522

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

15.1

527

3650

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.8

15.0

234

1335

D01BA02

ATC

terbinafine; oral

1.2

15.0

2125

17969

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

1.9

15.0

181

954

H02AB09

ATC

hydrocortisone; systemic

1.9

15.0

178

933

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.0

15.0

149

734

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.5

15.0

450

3023

SPAT1252

SPAT

Overall medication plan or its review

1.5

14.9

543

3789

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.8

14.8

252

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

14.8

413

2731

R81

ICPC

Pneumonia

1.7

14.8

268

1596

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

4.2

14.8

K08.80

ICD-10 Finland

Toothache NOS

1.4

14.7

659

4774

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.2

14.7

184

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.3

14.7

164

K04.0

ICD-10 Finland

Pulpitis

1.4

14.7

686

5007

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

14.7

795

5944

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

14.7

1260

10058

TGC00

NOMESCO Finland

Bronchial lavation

1.8

14.6

197

1076

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

5.1

14.5

SGA01

NOMESCO Finland

Emergency treatment

1.3

14.5

1263

10095

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.3

14.5

104

449

WX872

NOMESCO Finland

Intensive care

1.5

14.5

391

2567

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.8

14.5

214

1203

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

3.3

14.4

161

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

14.4

409

2714

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

14.4

801

6013

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.7

14.4

241

1404

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

14.4

389

2554

S22

ICPC

Nail symptom/complaint

1.5

14.4

479

3286

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.7

14.4

257

1525

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.3

14.4

102

439

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

14.4

287

1754

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

14.3

1108

8723

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

14.3

344

2200

D06AX01

ATC

fusidic acid; topical

1.4

14.3

706

5202

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

14.3

484

3332

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.3

14.2

107

472

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

4.6

14.2

R03AC13

ATC

formoterol; inhalant

1.5

14.2

399

2643

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

14.2

319

2008

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

3.2

14.2

168

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

14.2

641

4654

B01AF03

ATC

edoxaban; oral

1.9

14.2

173

916

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

14.1

534

3753

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

14.1

189

1030

S70.0

ICD-10 Finland

Contusion of hip

1.6

14.1

295

1823

J01FA15

ATC

telithromycin; oral

1.4

14.1

793

5963

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

3.9

14.1

102

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

14.1

373

2438

WF004

NOMESCO Finland

Palliative radiotherapy

1.9

14.1

171

904

M48.0

ICD-10 Finland

Spinal stenosis

1.3

14.1

981

7615

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.4

14.1

400

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.0

14.0

148

745

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

14.0

183

990

R20.2

ICD-10 Finland

Paraesthesia of skin

1.4

14.0

540

3810

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

14.0

109

488

C05AA08

ATC

fluocortolone; rectal, topical

1.3

14.0

1106

8731

SPAT1097

SPAT

Recording of ECG

1.3

14.0

1178

9378

R18

ICD-10 Finland

Ascites

2.0

14.0

145

726

R4110, ,

SPAT

1.4

13.9

673

4940

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

13.9

556

3950

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

13.9

331

2113

PH7ZT

NOMESCO Finland

Intravenous removal of filter to inferior vena cava

30.0

13.9

U04

ICPC

Incontinence urine

1.5

13.9

403

2689

SPAT1336

SPAT

Request for examination

1.7

13.8

278

1702

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

13.8

550

3904

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

13.8

797

6018

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.9

13.8

158

819

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

13.8

287

1773

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

13.8

1013

7921

E86

ICD-10 Finland

Volume depletion

1.8

13.7

185

1011

R00.2

ICD-10 Finland

Palpitations

1.4

13.7

596

4300

KBV10

NOMESCO Finland

Removal of stent from ureter

2.6

13.6

292

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.5

13.6

359

2344

D07AD01

ATC

clobetasol; topical

1.3

13.6

1335

10826

H05BX01

ATC

cinacalcet; oral

2.9

13.6

209

B35.3

ICD-10 Finland

Tinea pedis

1.6

13.5

331

2125

XX5WT

NOMESCO Finland

Laser therapy with ultrasound guidance

+∞

13.5

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

13.5

364

2389

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.6

13.5

320

2040

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

34.0

13.5

D01AE16

ATC

amorolfine; topical

1.3

13.5

928

7190

J01FA01

ATC

erythromycin; systemic

1.3

13.5

1017

7980

PH7UT

NOMESCO Finland

Removal of thrombosis from vein of lower extremity or pelvis or from vena cava inferior

140.2

13.4

H57.1

ICD-10 Finland

Ocular pain

1.6

13.4

270

1653

XF402

NOMESCO Finland

ECG with work load test

1.3

13.4

821

6253

J05AB01

ATC

aciclovir; systemic

1.2

13.4

1790

15025

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

13.4

231

1359

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.8

13.3

178

971

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.7

13.3

227

1331

U01

ICPC

Dysuria/painful urination

1.4

13.3

574

4134

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.2

13.3

113

525

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

13.2

290

1814

S09

ICPC

Infected finger/toe

1.7

13.2

241

1438

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

13.2

532

3783

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

13.2

366

2417

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

13.2

269

1653

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

13.2

617

4505

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.4

13.2

357

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

13.0

281

1751

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

13.0

143

731

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

13.0

225

1324

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.3

13.0

427

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.2

13.0

111

517

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.6

13.0

294

J05AB11

ATC

valaciclovir; oral

1.3

13.0

1141

9130

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1.6

12.9

271

1677

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

10.0

12.9

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

12.9

963

7541

RD211, ,

NOMESCO Finland

1.6

12.9

335

2182

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.1

12.9

120

578

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.7

12.8

213

1239

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

4.4

12.8

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.4

12.8

549

3951

XX6KT

NOMESCO Finland

Other sclerotherapy

11.5

12.8

N01

ICPC

Headache

1.3

12.8

733

5530

JFB00

NOMESCO Finland

Partial resection of small intestine

2.0

12.8

131

654

E66

ICD-10 Finland

Obesity

1.5

12.7

371

2477

S08

ICPC

Skin colour change

1.5

12.7

405

2754

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.9

12.7

152

800

R06.2

ICD-10 Finland

Wheezing

1.6

12.7

315

2030

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

4.2

12.7

K04.08

ICD-10 Finland

Other specified pulpit

1.4

12.7

532

3814

RS121, ,

NOMESCO Finland

3.0

12.6

175

SPAT1325

SPAT

Vaccination

1.2

12.6

2765

24300

T14.5

ICD-10 Finland

Injury of blood vessel(s) of unspecified body region

3.1

12.6

170

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.8

12.6

224

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1.5

12.6

375

2517

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

5.5

12.6

SPAT1283

SPAT

Restricted health certificate

1.3

12.6

1155

9290

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

12.5

200

1151

K92.0

ICD-10 Finland

Haematemesis

1.8

12.5

168

918

I82.20

ICD-10 Finland

Emboli and thrombosis of the superior vena cava

+∞

12.5

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

12.5

1900

16146

XPX08

NOMESCO Finland

Intraoperative flow measurement

2.6

12.5

282

ZXE40

NOMESCO Finland

More than seven and less than nine hours

1.8

12.5

172

948

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.6

12.5

250

1531

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.8

12.4

179

1000

A49.0

ICD-10 Finland

Staphylococcal infection, unspecified site

3.8

12.4

N05BA06

ATC

lorazepam; systemic, sublingual

1.5

12.4

400

2729

M54.3

ICD-10 Finland

Sciatica

1.4

12.4

466

3276

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.0

12.4

139

717

M02AA10

ATC

ketoprofen; topical

1.3

12.3

1295

10583

K59.0

ICD-10 Finland

Constipation

1.5

12.3

428

2964

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

2.9

12.3

194

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

1.8

12.3

173

960

TPH00

NOMESCO Finland

Phlebotomy

3.2

12.3

147

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

12.2

611

4511

R09.1

ICD-10 Finland

Pleurisy

1.9

12.2

138

713

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.0

12.2

126

631

Z51.88

ICD-10 Finland

Other specified medical care

1.9

12.2

155

833

KMAK, ,

NOMESCO Finland

1.2

12.2

4442

40621

L18

ICPC

Muscle pain

1.6

12.1

296

1901

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

12.1

236

1434

K22

ICPC

Risk factor cardiovascular disease

1.5

12.1

440

3071

PH2DE, ,

SPAT

4.4

12.1

L01

ICPC

Neck symptom/complaint

1.3

12.1

1200

9737

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.6

12.1

253

1566

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

2.8

12.1

207

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.6

12.0

307

1993

M79.7

ICD-10 Finland

Fibromyalgia

1.6

12.0

258

1608

D91

ICPC

Abdominal hernia other

2.2

12.0

423

D03BA52

ATC

collagenase, combinations; topical

3.2

12.0

144

RT274, ,

NOMESCO Finland

5.2

12.0

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

12.0

718

5452

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

12.0

406

2798

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.0

11.9

124

622

SPAT1104

SPAT

Monitoring of emergency patient

1.4

11.9

499

3575

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.0

11.9

118

582

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

11.9

494

3535

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.9

11.9

145

769

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.7

11.8

214

1276

JAH00

NOMESCO Finland

Laparotomy

1.7

11.8

204

1201

U05

ICPC

Urination problems other

1.5

11.8

369

2501

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

11.8

910

7156

I74.2

ICD-10 Finland

Embolism and thrombosis of arteries of upper extremities

3.9

11.8

JAF10

NOMESCO Finland

Repair of umbilical hernia

1.8

11.8

171

958

NK6AN

NOMESCO Finland

Total body bone isotope imaging

1.7

11.8

203

1195

D07AA02

ATC

hydrocortisone; topical

1.3

11.8

1028

8215

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

11.8

973

7722

E000006, ,

ATC

1.4

11.8

501

3601

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

1.9

11.8

147

786

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

11.8

422

2940

G04BD08

ATC

solifenacin; oral

1.4

11.7

500

3593

M10

ICD-10 Finland

Gout

1.5

11.7

328

2172

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

3.2

11.7

146

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.6

11.7

244

1509

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

11.7

561

4113

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

11.7

211

1257

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.7

11.7

199

1167

L30.3

ICD-10 Finland

Infective dermatitis

1.6

11.7

251

1564

B02.9

ICD-10 Finland

Zoster without complication

1.4

11.7

495

3555

137

Kela drug reimbursment

Uraemia requiring dialysis

2.5

11.7

274

WZA00

NOMESCO Finland

Concise certificate

1.4

11.7

463

3287

R04.2

ICD-10 Finland

Haemoptysis

1.6

11.6

247

1535

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

1.8

11.6

178

1013

J80

ICD-10 Finland

Adult respiratory distress syndrome

3.7

11.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

11.6

364

2469

HAC20

NOMESCO Finland

Total mastectomy

1.5

11.6

318

2097

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.1

11.6

102

481

6BA02, ,

NOMESCO Finland

4.1

11.6

K27

ICPC

Fear cardiovascular disease other

2.3

11.5

342

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

11.5

572

4219

L01BA01

ATC

methotrexate; systemic

1.6

11.5

277

1775

321

Kela drug reimbursment

Paricalcitol and cinacalcet

2.8

11.4

202

R03AC12

ATC

salmeterol; inhalant

1.5

11.4

332

2218

D45

ICD-10 Finland

Polycythaemia vera

2.4

11.4

313

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.5

11.4

391

2701

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

11.4

314

2074

S91.3

ICD-10 Finland

Open wound of other parts of foot

1.8

11.4

170

961

C08CA01

ATC

amlodipine; oral

1.2

11.4

3325

29863

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

2.1

11.4

459

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

11.4

280

1804

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

11.3

167

940

M09AX01

ATC

hyaluronic acid; parenteral

1.5

11.3

354

2400

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

11.3

2195

19057

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.8

11.3

163

911

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.2

11.3

440

S09.9

ICD-10 Finland

Unspecified injury of head

2.0

11.3

112

553

T14.0

ICD-10 Finland

Superficial injury of unspecified body region

2.1

11.3

107

520

L76

ICPC

Fracture: other

1.6

11.3

231

1424

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

11.3

3773

34227

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

11.3

803

6250

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

2.5

11.3

261

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

8.9

11.2

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.8

11.2

150

820

D01AC02

ATC

miconazole; topical

1.4

11.2

567

4196

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

1.8

11.2

169

959

ZXD20

NOMESCO Finland

Day surgery

1.3

11.2

1005

8059

M01AB01

ATC

indometacin; systemic, rectal

1.4

11.2

547

4026

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.5

11.2

311

2059

I86.1

ICD-10 Finland

Scrotal varices

4.6

11.2

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

11.2

321

2140

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

11.1

492

3559

E87.5

ICD-10 Finland

Hyperkalaemia

1.9

11.1

131

687

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

11.1

881

6952

4512A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of lower extremities, unspecified

20.0

11.1

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.5

11.1

298

1957

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.7

11.1

177

1020

J01XX08

ATC

linezolid; systemic

2.7

11.1

211

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

3.7

11.1

J01DA06

ATC

[U] cefuroxime

1.3

11.1

1124

9143

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

11.1

873

6886

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.0

11.1

115

578

H92.0

ICD-10 Finland

Otalgia

1.4

11.0

427

3017

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

3.3

11.0

121

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

11.0

342

2317

M79.3

ICD-10 Finland

Panniculitis, unspecified

3.8

11.0

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.6

11.0

229

1418

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.6

11.0

217

1326

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

11.0

3720

33760

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.7

10.9

174

1002

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

1.9

10.9

141

762

WVA20, ,

SPAT

1.7

10.9

188

1107

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

1.6

10.9

218

1335

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.8

10.9

154

856

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.4

10.9

435

3091

R01AD12

ATC

fluticasone furoate; nasal

1.2

10.9

2502

22028

SPAT1227

SPAT

Substance abuse rehabilitation

2.8

10.9

185

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

353

343

10.61

319.35

1.3

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

976

2630

3.98

316.97

3.5

3.0

0.37

0.34

u/ml

1.32

615

1472

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

859

972

9.52

307.65

1.3

1.2

4.07

3.51

u/ml

0.29

286

315

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

917

911

10.91

307.65

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1274

2130

6.65

307.65

2.2

2.1

97.41

91.66

14.58

1175

2053

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

537

665

8.45

307.65

2.5

2.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

679

641

11.24

307.65

1.2

1.1

95.26

96.81

0.53

607

605

(3022217) INR in Platelet poor plasma by Coagulation assay

6505

40141

2.58

307.65

21.8

13.7

1.32

1.25

inr

6.92

1998

11482

(3036489) Thrombin time

1372

2674

5.74

307.65

2.0

21.55

21.34

0.35

1088

2361

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

824

946

9.35

307.65

1.3

1.2

3.85

4.13

u/ml

0.20

355

401

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4824

17804

4.11

307.65

2.3

1.7

1.62

1.10

mg/l

15.04

3889

13582

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1066

1984

5.86

307.65

2.5

2.4

187.18

190.72

0.58

987

1889

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

907

867

11.34

307.65

1.1

119.02

119.03

0.00

784

788

(3023368) Bacteria identified in Blood by Culture

3978

23014

2.16

294.69

5.6

4.1

—

(3033658) Prothrombin time (PT) actual/Normal

3742

22162

2.06

251.51

5.1

3.7

88.72

90.98

5.40

3618

21612

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

311

394

8.10

229.26

1.2

1.1

1.08

1.07

ratio

0.51

118

139

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

267

281

9.72

227.77

1.1

1.0

94.83

96.36

0.26

199

225

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6277

45604

1.91

221.59

8.4

5.9

10.79

11.23

umol/l

2.09

6030

43242

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

753

2175

3.65

219.23

3.0

2.5

3.52

3.65

g/l

1.53

716

2068

(3006504) Eosinophils/100 leukocytes in Blood

5674

40666

1.84

200.82

7.9

5.9

2.78

2.84

1.30

5348

37848

(3013650) Neutrophils [#/volume] in Blood by Automated count

6685

50410

1.87

200.62

12.7

8.9

4.06

4.13

e9/l

1.32

5923

43815

(3019069) Monocytes/100 leukocytes in Blood

5691

40913

1.83

198.53

8.3

6.2

8.65

8.57

1.00

5364

38143

(3022096) Basophils/100 leukocytes in Blood

5516

39328

1.83

197.23

7.9

5.9

0.65

0.68

2.58

5195

36520

(40760892) CBC W Ordered Manual Differential panel - Blood

5640

40640

1.82

193.19

8.4

6.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

6729

51207

1.84

191.92

6.1

4.5

6.62

6.74

mmol/l

5.23

6446

47837

(3002030) Lymphocytes/100 leukocytes in Blood

5772

41997

1.81

190.26

8.0

6.0

26.81

27.76

8.53

5463

39250

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2385

13073

2.06

189.13

2.8

2.0

30.40

29.70

4.83

2314

12685

(3013115) Eosinophils [#/volume] in Blood

6073

44970

1.81

187.67

7.9

5.9

0.19

e9/l

3.15

5365

39284

(3018010) Neutrophils/100 leukocytes in Blood

5692

41396

1.80

186.38

7.7

5.8

58.04

57.36

4.04

5377

38666

(3006315) Basophils [#/volume] in Blood

5909

43554

1.79

183.88

7.5

5.7

0.04

e9/l

1.71

5145

37470

(3001604) Monocytes [#/volume] in Blood

5895

43429

1.79

183.67

7.5

5.7

0.59

e9/l

0.02

5133

37389

(3019198) Lymphocytes [#/volume] in Blood

6014

44662

1.79

181.37

7.6

5.8

1.82

1.94

e9/l

4.70

5352

39329

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5920

43762

1.79

181.37

9.4

6.5

1.21

mmol/l

0.03

5075

37149

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8293

68018

1.97

180.57

11.0

7.3

79.59

77.93

u/l

2.02

7924

64095

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5408

39451

1.75

168.56

8.2

5.8

1.21

mmol/l

0.02

5006

35874

(3024561) Albumin [Mass/volume] in Serum or Plasma

5247

38036

1.74

166.50

6.4

4.6

34.61

35.58

g/l

28.94

4896

35274

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2320

13637

1.89

145.26

2.2

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3635

24481

1.73

144.21

3.1

2.9

1509.07

1440.30

ng/l

0.25

3139

20996

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

219

317

7.03

143.44

1.2

1.1

7.82

9.06

u/ml

0.12

(3002582) Erythrocytes [#/volume] in Urine

3849

26429

1.71

141.72

4.4

3.1

74.61

84.40

e6/l

0.22

3076

20138

(3042936) Bacteria identified in Isolate by Culture

2050

11758

1.92

137.44

2.4

2.0

—

(3018095) Leukocytes [#/volume] in Urine

4302

30808

1.66

132.68

5.1

3.6

82.27

98.07

e6/l

0.86

3235

21740

(3031040) Bacteria [#/volume] in Urine by Automated count

7075

57472

1.68

132.33

5.9

4.3

1751.48

1749.50

e6/l

0.00

109

794

(3044640) Blood type and Crossmatch panel - Blood

3940

27605

1.68

132.08

3.0

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5370

40832

1.63

129.29

3.1

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

3539

24212

1.69

129.20

4.3

3.1

0.40

0.43

e6/l

0.28

2821

18329

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2299

13959

1.82

127.67

4.3

3.2

0.81

0.82

mmol/l

3.12

2154

13077

(3037467) Urinalysis macro (dipstick) panel - Urine

7308

60192

1.67

126.25

5.8

4.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

173

230

7.63

122.23

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4524

33293

1.62

121.98

4.3

3.5

41.93

83.56

ng/l

1.41

3234

22594

(36304419) Bacteria [Presence] in Urine

3431

23568

1.67

121.69

4.2

3.0

—

(3034426) Prothrombin time (PT)

176

240

7.44

121.62

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1734

9787

1.92

120.45

2.1

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3862

27469

1.63

118.69

3.1

2.5

76.49

63.08

u/l

0.29

3605

25379

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2068

12430

1.82

117.53

3.2

2.4

2.30

2.33

g/l

1.98

1913

11493

(3000850) Epithelial cells [#/volume] in Urine

2766

18231

1.70

113.17

3.5

2.5

5.44

5.65

e6/l

0.35

2512

16297

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9718

87960

2.12

111.11

24.2

13.7

23.70

23.90

mg/l

0.24

8659

69571

(3022948) Iron [Moles/volume] in Serum or Plasma

2177

13505

1.77

110.39

3.2

2.4

12.40

13.02

umol/l

3.44

2046

12547

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1938

11625

1.81

110.09

3.3

2.5

22.15

22.50

0.47

1707

9907

(3018418) pH of Serum or Plasma

3650

25988

1.61

109.46

6.1

4.0

7.40

0.01

770

4824

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

159

222

7.25

107.59

1.1

—

(3026782) Osmolality of Urine

2649

17457

1.69

107.54

3.9

2.9

529.38

540.95

mosm/kgh2o

1.93

2334

14946

(3021589) Normoblasts [#/volume] in Blood

5003

38453

1.56

107.36

13.6

9.2

0.00

e9/l

0.23

4136

31363

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3049

20933

1.64

105.12

2.7

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1620

9316

1.87

104.98

2.1

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1652

9652

1.84

101.48

5.0

4.2

244.49

243.29

u/l

0.11

1564

9100

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1610

9359

1.85

100.44

2.1

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1185

6233

2.01

99.79

1.8

1.6

—

(3026008) Bacteria identified in Urine by Culture

3685

26797

1.57

98.39

3.7

3.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1336

7418

1.91

95.84

10.3

7.1

10.76

9.86

mmol/l

3.98

1271

7053

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1795

10980

1.76

93.87

9.0

5.6

1.05

1.03

mmol/l

1.29

1691

10197

(3013707) Erythrocyte sedimentation rate by Westergren method

7594

65194

1.56

91.24

5.1

4.0

13.94

12.25

mm/h

17.33

7093

60301

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2508

16918

1.63

90.43

4.5

3.7

392.76

513.72

ng/l

0.49

1943

13133

(40758558) Short blood count panel - Blood

3109

22106

1.57

89.70

9.7

6.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3950

29629

1.53

89.38

4.5

3.4

2.35

2.36

mmol/l

3.88

3486

25967

(3026493) Urate [Moles/volume] in Serum or Plasma

3219

23263

1.55

85.55

3.2

2.5

3301.48

4657.54

umol/l

1.28

2763

20300

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2122

13917

1.65

84.83

3.8

2.9

3.05

2.72

e6/l

0.67

1210

7527

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

438

1634

2.75

81.50

7.0

5.2

505.21

2210.20

iu/ml

0.85

231

(3019550) Sodium [Moles/volume] in Serum or Plasma

9813

90764

1.95

80.65

25.4

15.8

139.71

139.66

mmol/l

1.06

9652

88490

(3023103) Potassium [Moles/volume] in Serum or Plasma

9824

91043

1.94

78.11

25.7

15.9

3.99

3.97

mmol/l

11.08

9651

88582

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

941

4957

1.98

78.03

1.9

1.7

—

(3000991) Gas panel - Venous blood

1226

7081

1.83

76.63

9.6

8.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2210

14997

1.60

75.79

3.5

2.7

1.05

1.32

e6/l

0.70

1307

8557

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2986

21679

1.52

75.76

2.5

2.2

3.20

2.92

mg/l

6.29

2566

18484

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1324

7885

1.77

74.55

5.5

3.7

5.83

5.82

kpa

0.15

1279

7670

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

109

155

7.09

72.58

1.2

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3717

28458

1.47

71.70

3.9

3.1

33.41

34.79

u/l

0.50

3522

26898

(3002032) Base excess in Venous blood by calculation

1310

7869

1.76

71.40

5.6

3.8

1.84

1.90

mmol/l

0.25

1131

6681

(3014111) Lactate [Moles/volume] in Serum or Plasma

1254

7450

1.77

70.99

7.7

6.9

1.27

1.34

mmol/l

1.43

1220

7252

(3012544) pH of Venous blood

1348

8196

1.74

70.32

5.4

3.7

7.38

7.37

0.08

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1569

9942

1.68

70.28

3.3

2.6

8.61

8.25

umol/l

0.20

1380

8581

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9127

83319

1.64

69.85

21.0

12.9

79.46

80.51

ml/min/173m2

4.52

8053

68907

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4631

37091

1.44

69.70

3.5

2.8

146.64

131.74

ug/l

1.91

4295

34243

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3488

26574

1.46

68.13

2.5

2.1

183.77

213.28

u/l

1.59

3303

24871

(3035350) Ketones [Presence] in Urine by Test strip

5227

42909

1.43

68.04

4.6

3.6

0.00

estimate

3.22

1237

8301

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

945

5220

1.89

67.67

4.1

3.3

5.15

5.14

kpa

0.14

897

4939

(3009343) pH of Capillary blood

933

5138

1.89

67.43

4.0

3.3

7.41

7.42

0.15

143

649

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4520

36208

1.43

67.10

2.6

2.2

76.24

2602.64

nmol/l

0.50

4071

32475

(3017181) Myelocytes/100 leukocytes in Blood

1226

7372

1.75

66.28

4.8

4.0

1.00

0.95

0.26

524

2481

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

900

4936

1.90

65.81

4.0

3.3

1.88

1.76

mmol/l

0.43

679

3660

(3021601) Nitrite [Presence] in Urine by Test strip

5211

42932

1.42

65.44

6.3

4.9

0.00

estimate

1.34

1177

7773

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1298

7964

1.72

65.21

2.4

2.1

0.21

g/l

1.77

1204

7425

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

672

3350

2.07

64.60

2.3

1.9

1.75

2.25

ug/l

0.64

596

2938

(3021440) Promyelocytes/100 leukocytes in Blood

1167

7011

1.75

63.11

4.7

4.0

0.11

0.12

0.06

470

2129

(3003396) Base excess in Arterial blood by calculation

1518

9786

1.64

63.01

7.5

7.2

0.97

1.06

mmol/l

0.39

1236

7764

(3009261) Glucose [Presence] in Urine by Test strip

5236

43402

1.40

62.20

4.7

3.6

0.00

estimate

0.14

1158

7568

(3027801) Oxygen [Partial pressure] in Arterial blood

1517

9811

1.64

62.10

7.5

7.1

11.89

12.45

kpa

4.02

1445

9361

(3002179) Metamyelocytes/100 leukocytes in Blood

1124

6712

1.75

62.03

4.6

3.8

0.75

0.69

0.37

459

2145

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1517

9814

1.64

62.01

7.5

7.1

5.08

kpa

0.04

1446

9372

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

335

1260

2.71

61.29

3.3

2.5

3230.05

1300.90

u/ml

0.47

(3024354) Oxygen [Partial pressure] in Venous blood

1088

6468

1.76

60.94

4.5

3.1

4.74

4.56

kpa

1.61

1043

6267

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1449

9317

1.64

60.59

4.5

4.0

16.64

27.29

ug/l

1.01

1181

7530

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

746

3965

1.95

59.78

6.0

4.1

24.12

mmol/l

0.02

728

3881

(3015736) pH of Urine

4282

34551

1.40

58.23

4.2

3.4

5.89

5.84

0.49

268

2566

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1357

8681

1.64

57.69

4.4

3.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1296

8218

1.66

57.00

3.1

2.4

36.30

45.23

u/l

0.48

1118

7059

(3025159) Blasts/100 leukocytes in Blood

1089

6653

1.71

55.04

4.8

4.0

0.36

0.34

0.03

392

1794

(3020630) Protein [Mass/volume] in Serum or Plasma

1137

7054

1.68

54.23

3.2

2.5

65.27

66.46

g/l

5.38

1047

6382

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

432

1940

2.28

53.97

1.8

1.6

—

(3016502) Oxygen saturation in Arterial blood

1349

8756

1.62

53.84

7.9

7.6

95.56

95.65

0.24

1295

8425

(3027945) Reticulocytes/100 erythrocytes in Blood

1446

9565

1.59

53.29

3.1

2.4

1.87

1.77

2.24

1280

8439

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

860

5007

1.78

51.41

1.7

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

1686

11651

1.53

50.98

1.4

1.3

560.30

520.92

titre

0.40

396

2466

(3019174) dRVVT (LA screen)

10.85

50.33

1.2

—

(3013512) EKG study

3244

25450

1.39

50.06

4.4

3.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4392

36192

1.36

49.92

2.2

2.0

94.69

96.03

pmol/l

1.06

2449

18636

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

412

1880

2.24

49.51

1.8

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6616

58099

1.36

49.50

3.8

3.0

53.65

47.81

u/l

4.97

6195

54024

(40768804) Tissue Pathology biopsy report

4381

36134

1.36

49.30

2.3

2.1

—

(3000494) Fungus identified in Specimen by Culture

1467

9907

1.56

49.09

1.6

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

501

2495

2.06

48.10

2.0

1.6

0.24

g/l

0.21

473

2361

(3021960) Folate [Moles/volume] in Serum or Plasma

2653

20230

1.41

47.91

1.6

1.5

18.77

20.55

nmol/l

8.68

2302

17264

(3044009) aPTT.lupus sensitive (LA screen)

10.66

47.89

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

563

2929

1.97

47.82

2.4

2.3

253.20

658.48

ug/l

4.11

537

2752

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

513

2584

2.03

47.74

2.0

1.6

1.18

1.19

g/l

0.35

486

2451

(3005719) IgG [Mass/volume] in Serum or Plasma

1008

6264

1.67

47.47

3.6

2.7

10.14

10.44

g/l

1.36

935

5735

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

777

4494

1.79

47.39

9.1

9.2

24.30

24.28

mmol/l

0.08

755

4362

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

7.94

47.20

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1847

13202

1.48

47.06

2.1

1.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1232

8079

1.59

46.68

8.4

8.0

121.59

121.33

g/l

0.17

1197

7855

(3019309) Folate [Moles/volume] in Red Blood Cells

2217

16439

1.44

46.58

1.9

1.7

1122.99

1166.43

nmol/l

1.37

1675

12365

(4035726) Immunohistochemistry procedure

1212

7947

1.59

45.90

1.5

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

326

1402

2.37

45.02

1.8

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1033

6552

1.64

44.79

5.5

3.7

111.13

90.65

ng/l

6.26

900

5618

(3017143) Hepatitis C virus Ab [Presence] in Serum

1329

8988

1.55

43.82

2.0

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

647

3633

1.83

43.45

1.8

1.5

21.58

15.71

u/ml

0.45

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1119

7293

1.60

43.34

2.9

2.8

187.22

196.96

ng/l

0.33

1026

6636

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

468

2361

2.03

43.34

1.8

1.7

—

(3022313) Gas panel - Capillary blood

655

3708

1.82

42.82

4.2

3.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

928

5802

1.66

42.50

2.9

2.3

—

(40761511) CBC panel - Blood by Automated count

9667

91472

1.58

41.78

20.9

12.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1098

7200

1.58

41.34

5.6

3.7

1.22

1.23

mmol/l

1.50

981

6254

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2169

16323

1.41

41.26

3.7

3.0

2.46

2.45

mmol/l

2.55

1886

14218

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

383

1828

2.14

41.13

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

383

1828

2.14

41.13

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

261

1064

2.49

40.56

6.1

6.8

12.22

11.68

mg/l

1.06

240

984

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

452

2312

2.00

40.25

1.8

1.4

20.36

15.41

iu/ml

0.27

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1568

11162

1.47

40.16

2.0

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

502

2665

1.93

40.12

3.5

3.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

316

1411

2.28

40.02

3.4

1.52

1.57

0.09

278

1252

(3010421) pH of Blood

435

2202

2.02

39.89

4.9

3.9

7.42

0.52

404

1998

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

170

561

3.06

39.63

1.3

1.5

12.38

12.44

umol/l

0.04

164

524

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

471

2458

1.96

39.59

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

1076

7109

1.57

39.11

3.5

2.4

72.16

69.70

e9/l

1.17

797

5397

(3048929) Epstein Barr virus Ab [Presence] in Serum

440

2259

1.99

38.77

1.4

1.2

—

(40768797) Stomach Pathology biopsy report

1665

12072

1.45

38.62

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

120

325

3.72

38.25

38.8

33.3

7.40

7.30

ug/l

0.23

114

291

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

323

1484

2.21

38.19

1.4

1.2

279.57

275.41

u/ml

0.09

223

933

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

849

5351

1.64

37.51

9.2

8.9

0.65

0.67

0.80

838

5314

(40767503) Oxygen content in Capillary blood by calculation

367

1790

2.09

37.24

3.0

2.5

16.54

16.30

0.50

198

921

(3012501) Base excess in Blood by calculation

382

1895

2.05

37.04

4.7

4.0

2.57

2.48

mmol/l

0.24

282

1280

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

334

1581

2.15

36.65

1.4

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

848

5374

1.63

36.62

9.3

9.0

93.63

93.96

0.84

843

5357

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1153

7849

1.53

36.49

2.3

2.2

355.91

378.48

nmol/l

3.54

1078

7177

(3028626) Oxygen [Partial pressure] in Capillary blood

362

1777

2.07

36.11

3.3

2.8

8.27

8.07

kpa

1.74

355

1736

(3002385) Erythrocyte distribution width [Ratio]

8208

75852

1.35

35.99

27.5

16.3

15.26

15.00

2.33

8117

74481

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

845

5376

1.62

35.90

9.1

8.8

1.41

1.37

0.44

835

5342

(3015235) Bicarbonate [Moles/volume] in Capillary blood

412

2126

1.98

35.78

3.3

3.0

24.81

mmol/l

0.00

406

2088

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

221

886

2.53

35.62

1.7

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

514

2868

1.83

35.15

1.7

1.6

188.25

310.47

titre

1.02

117

(1616796) Gas panel - Central venous blood

370

1850

2.04

35.11

4.6

3.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

570

3299

1.77

34.49

2.7

2.2

7.43

7.45

g/l

0.09

518

2965

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

569

3294

1.77

34.40

2.7

2.2

3.74

3.68

g/l

0.38

518

2958

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

569

3297

1.77

34.29

2.7

2.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

772

4864

1.63

34.07

2.2

1.9

1.17

1.39

g/l

2.79

707

4433

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

554

3197

1.77

33.86

4.5

3.5

25.04

24.81

mmol/l

1.02

519

2918

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

308

1462

2.14

33.57

1.9

1.4

112.19

115.46

u/ml

0.22

318

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

250

1091

2.32

33.45

1.6

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

329

1609

2.08

33.17

1.8

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

286

1326

2.19

33.09

1.8

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

286

1326

2.19

33.09

1.8

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

285

1322

2.19

32.94

2.1

1.9

1.65

1.71

mmol/l

0.51

278

1290

(3006184) Hemoglobin [Mass/volume] in Capillary blood

373

1917

1.98

32.78

2.5

2.2

129.73

129.51

g/l

0.06

283

1359

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

406

2148

1.93

32.77

4.5

2.9

1.85

1.52

mg/l

6.97

373

1964

(3010375) cycloSPORINE [Mass/volume] in Blood

115

337

3.44

32.63

30.6

26.1

110.13

114.35

ug/l

0.31

278

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

327

1609

2.06

32.43

1.8

1.4

12.20

16.78

u/ml

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9814

93905

1.53

32.15

15.2

10.2

26.06

26.31

u/l

0.59

9568

90480

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

737

4675

1.62

31.59

10.1

9.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

530

3086

1.75

31.39

2.7

2.2

9.99

10.11

g/l

0.24

474

2730

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6010

53750

1.27

30.81

3.2

2.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

628

3851

1.67

30.77

2.1

1.6

1.64

1.58

g/l

0.98

564

3271

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

527

3082

1.75

30.73

2.7

2.3

2.95

2.94

g/l

0.03

475

2748

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

531

3115

1.74

30.63

3.9

3.4

4082.00

561.54

u/ml

0.89

449

2650

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

485

2779

1.78

30.36

2.8

2.3

0.88

0.87

g/l

0.02

422

2371

(3041096) Erythrocytes [Presence] in Urine by Automated

2828

23087

1.31

30.06

4.5

3.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

469

2669

1.79

30.04

4.3

3.3

54.26

74.73

mg/l

0.46

377

2173

(3021901) Oxygen saturation in Capillary blood

304

1504

2.05

29.73

3.3

2.8

—

(3025941) Bacteria identified in Stool by Culture

752

4865

1.59

29.65

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

311

1555

2.03

29.55

1.9

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

467

2669

1.78

29.48

4.3

3.3

36.75

48.56

mg/l

1.14

373

2174

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

458

2607

1.79

29.31

4.1

3.3

21.05

3.27

ratio

0.43

207

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

649

4064

1.64

29.27

4.1

2.8

1.30

1.27

0.34

644

4041

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1936

15026

1.35

29.17

1.3

49.98

33.84

iu/ml

0.69

588

4824

(3004119) Hemoglobin [Mass/volume] in Venous blood

797

5246

1.56

29.15

4.9

3.4

126.93

128.94

g/l

1.80

784

5134

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

586

3592

1.67

28.74

2.3

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

187

771

2.45

28.48

1.2

—

(3022145) Colonoscopy Study observation

1335

9818

1.41

27.89

1.4

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3877

33193

1.26

27.66

5.0

3.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

192

815

2.38

27.44

2.4

2.5

—

(3019225) pH of Specimen

1195

8670

1.43

26.89

5.5

4.1

—

(3019060) Gas panel - Arterial blood

833

5638

1.52

26.76

4.9

—

(40761536) Microorganisms panel - Urine sediment

1014

7169

1.46

26.21

5.3

3.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7321

67587

1.26

26.19

4.3

4.0

14.82

14.78

pmol/l

0.73

6706

61535

(3021879) Hepatitis B virus core Ab [Presence] in Serum

862

5903

1.50

26.17

1.6

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

438

2546

1.75

26.09

2.4

2.2

36.86

37.88

g/l

2.88

385

2202

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

535

3291

1.66

25.87

2.0

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2494

20357

1.29

25.82

4.3

3.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

110

363

3.05

25.79

1.1

4.00

3.33

iu/ml

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8595

81046

1.30

25.32

5.2

4.7

2.04

2.13

mu/l

0.25

7925

74244

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

421

2446

1.75

25.13

2.4

2.2

0.01

0.04

g/l

1.55

395

2221

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

392

2232

1.78

25.08

2.5

2.3

0.00

g/l

-0.00

369

2044

(3024928) Oxygen saturation in Venous blood

329

1775

1.88

25.07

4.4

3.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

202

912

2.24

25.04

3.5

3.7

—

(3042733) HLA Ab [Presence] in Serum

244

3.50

24.99

5.9

5.2

—

(3037121) Protein [Mass/volume] in Urine

475

2859

1.69

24.95

3.9

3.0

0.41

0.30

g/l

0.56

209

1153

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

110

372

2.98

24.73

2.2

1.9

97.83

101.06

0.46

100

345

(3007164) IgA [Mass/volume] in Serum or Plasma

2018

16103

1.31

24.59

1.7

1.4

2.44

2.41

g/l

0.26

1257

9686

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

395

2272

1.77

24.42

2.5

2.3

0.00

g/l

0.92

369

2053

(40768446) Kidney Pathology biopsy report

305

3.17

24.04

2.0

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

359

2022

1.80

23.84

1.7

1.6

17794.35

14825.44

e6/l

0.39

268

1465

(3029937) Albumin [Presence] in Urine by Test strip

2759

23047

1.27

23.28

5.2

4.0

0.00

estimate

0.31

1127

7508

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

130

497

2.64

23.25

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

380

2195

1.76

23.16

1.4

1.3

10.21

4.63

u/ml

0.40

226

(3042517) Benzodiazepines panel - Urine

6.35

23.04

3.2

2.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

356

2023

1.79

22.95

4.6

3.4

—

(3002256) Pathology report gross observation

1505

11625

1.34

22.86

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

1349

10255

1.36

22.75

2.6

2.2

175.25

137.23

ug/g

2.23

1091

8086

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

385

2248

1.74

22.60

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

382

2227

1.74

22.55

1.4

1.3

10.10

5.92

u/ml

0.55

357

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

432

2605

1.69

22.55

1.9

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1787

14213

1.31

22.03

1.3

14.80

12.66

u/ml

0.35

643

5601

(3009542) Hematocrit [Volume Fraction] of Blood

10065

97639

1.50

21.99

34.0

20.4

39.74

40.31

5.72

9549

91298

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

336

1903

1.79

21.92

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

288

1562

1.87

21.63

4.3

3.8

24.36

35.79

u/ml

1.86

279

1511

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

200

955

2.12

21.61

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

189

885

2.16

21.47

1.8

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

270

1438

1.90

21.46

1.6

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

148

629

2.37

21.20

1.6

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

187

878

2.15

21.11

3.4

56.41

56.98

0.13

162

739

(3000570) Elastase.pancreatic [Mass/mass] in Stool

414

2515

1.67

21.02

1.4

261.41

274.36

ug/g

0.61

242

1474

(3044941) Cell count panel - Synovial fluid

243

1258

1.95

21.02

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

329

1879

1.77

20.88

1.5

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

293

1619

1.83

20.76

3.1

2.3

31.49

33.18

umol/l

0.71

270

1442

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

218

1093

2.02

20.67

1.5

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

400

2420

1.68

20.64

1.4

1.3

60.35

41.91

u/ml

0.55

141

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

460

2886

1.62

20.58

2.8

2.6

—

(3044889) 12 lead EKG panel

6715

62073

1.22

20.55

4.2

3.7

—

(3024731) MCV [Entitic volume]

10066

97775

1.48

20.50

33.7

20.2

91.35

91.07

7.29

9960

96341

(3035941) MCH [Entitic mass]

10065

97767

1.48

20.45

33.6

20.2

30.23

30.32

5.73

9960

96336

(3007461) Platelets [#/volume] in Blood

10060

97720

1.47

20.32

33.8

20.3

248.11

252.47

e9/l

8.74

9882

95150

(3010813) Leukocytes [#/volume] in Blood

10066

97795

1.48

20.26

33.8

20.3

6.81

6.73

e9/l

1.94

9868

94910

(3026361) Erythrocytes [#/volume] in Blood

10065

97785

1.48

20.24

33.8

20.3

4.43

4.49

e12/l

26.56

9865

94928

(3000963) Hemoglobin [Mass/volume] in Blood

10066

97808

1.47

20.10

34.0

20.4

132.90

135.32

g/l

49.14

9964

96385

(3037756) Immunofixation for Serum or Plasma

306

1731

1.79

20.07

2.0

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

314

1790

1.78

20.07

4.0

3.3

1133.98

583.20

u/ml

0.41

281

1634

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

111

4.43

20.03

5.1

5.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

303

2.95

19.87

2.9

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

116

4.33

19.84

12.9

10.5

5.37

5.76

mmol/l

0.40

116

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

174

820

2.14

19.49

1.8

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

761

5398

1.44

19.17

6.9

7.0

24.68

24.56

mmol/l

0.40

718

5129

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

314

1820

1.75

18.97

1.3

1.2

9.46

4.04

u/ml

0.29

137

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

235

1248

1.90

18.89

1.6

1.4

—

(3045142) Bone marrow Pathology biopsy report

183

895

2.06

18.62

1.4

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

184

905

2.05

18.44

1.7

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

184

905

2.05

18.44

1.7

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

310

1814

1.73

18.12

1.6

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

152

3.70

17.99

1.3

64.83

120.23

mg/l

0.29

113

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

217

1142

1.92

17.95

1.6

1.4

—

(3021788) Differential panel - Synovial fluid

268

1513

1.79

17.75

1.6

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

667

4683

1.45

17.74

4.3

3.3

78.36

63.36

u/ml

0.31

645

4508

(3027273) Bicarbonate [Moles/volume] in Venous blood

605

4177

1.48

17.55

4.9

3.3

25.28

25.22

mmol/l

0.17

593

4054

(3030981) Hyaline casts [#/volume] in Urine by Automated count

654

4592

1.45

17.39

3.7

2.6

0.29

e6/l

0.02

640

4468

(3023420) DNA double strand Ab [Units/volume] in Serum

180

898

2.02

17.38

1.8

1.5

54.11

21.16

iu/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

323

2.74

17.16

2.2

6.0

1789.22

768.31

mg/l

0.25

238

(3049717) Cytology report of Urine Cyto stain

483

3203

1.53

17.03

2.6

2.7

—

(3017732) Neutrophils [#/volume] in Blood

825

6062

1.39

16.99

3.7

2.9

4.50

5.03

e9/l

0.77

648

4866

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

428

2.47

16.59

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

383

2425

1.60

16.55

1.6

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

536

3661

1.49

16.41

1.9

38.96

39.01

u/l

0.02

476

3238

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

242

1362

1.79

16.23

1.3

1.2

53.13

35.66

u/l

0.66

211

1178

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

104

427

2.45

16.19

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

149

713

2.11

16.13

1.9

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

149

713

2.11

16.13

1.9

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

149

713

2.11

16.13

1.9

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

264

2.85

15.85

1.1

—

(40768443) Skin Pathology biopsy report

548

3789

1.47

15.79

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

105

443

2.38

15.42

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

280

2.76

15.34

1.1

—

(3024471) HLA-A [Type]

242

2.90

15.30

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

104

440

2.38

15.18

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

499

3416

1.48

15.12

1.3

1.2

1.24

0.95

u/ml

0.21

313

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8500

81278

1.22

14.98

6.2

5.7

39.97

39.83

mmol/mol

0.70

7879

75095

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

345

2190

1.59

14.78

1.2

1.3

—

(3024932) HLA-DR beta [Type]

236

2.89

14.78

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

342

2172

1.59

14.63

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

520

3615

1.46

14.58

5.5

5.1

1.61

1.65

0.43

485

3386

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

283

2.70

14.49

2.1

1.8

2496.71

74996.55

u/ml

1.12

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

381

2487

1.55

14.47

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

336

2.54

14.38

2.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

394

2595

1.54

14.37

1.6

0.30

9.86

iu/ml

0.90

571

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

129

612

2.12

14.34

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

332

2.54

14.22

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

332

2.54

14.22

2.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

383

2516

1.54

14.14

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

975

7568

1.32

13.97

2.5

2.3

7.63

7.37

ug/l

0.09

827

6574

(3007930) Methemoglobin/Hemoglobin.total in Blood

511

3570

1.45

13.97

5.6

5.2

0.87

0.89

0.70

477

3348

(40759836) Histone Ab [Presence] in Serum by Immunoblot

128

612

2.10

13.95

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

237

1387

1.72

13.95

1.9

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

128

613

2.10

13.90

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

235

1374

1.73

13.88

1.6

0.68

0.76

g/l

0.50

180

1048

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

199

1110

1.81

13.82

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

229

2.85

13.77

1.2

1.1

96.24

87.85

1.12

100

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

128

618

2.08

13.61

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

128

618

2.08

13.61

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

128

619

2.08

13.56

1.3

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

508

2.20

13.53

1.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

381

2525

1.53

13.53

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

226

2.84

13.51

1.2

1.1

115.67

107.21

0.77

206

(21494434) Karyotype in Bone marrow

139

695

2.01

13.45

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

780

5903

1.35

13.31

2.4

23.38

23.73

au/ml

0.03

455

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

121

3.56

13.19

5.4

5.1

60.18

43.30

ug/min

0.79

(3018405) Lactate [Moles/volume] in Arterial blood

435

2987

1.48

13.02

3.9

4.0

1.36

1.39

mmol/l

0.27

422

2941

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2159

18512

1.21

13.00

1.3

1.2

1.49

1.76

u/ml

0.62

592

4986

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

126

616

2.06

12.98

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

193

1089

1.79

12.93

1.5

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

137

693

1.99

12.86

1.3

1.2

41.00

48.70

u/ml

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

134

674

2.00

12.78

1.3

1.2

90.67

62.24

u/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

193

1093

1.78

12.78

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

192

1088

1.78

12.69

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

348

2296

1.53

12.64

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

192

1090

1.78

12.61

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

134

678

1.99

12.58

1.3

1.2

67.85

36.15

u/ml

0.60

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

265

1644

1.63

12.54

5.0

3.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

170

932

1.84

12.53

7.0

13.3

7.18

7.58

mmol/l

0.64

140

774

(3025468) Yersinia sp identified in Specimen by Organism specific culture

191

1087

1.77

12.45

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

220

2.78

12.42

1.2

95.81

89.04

0.66

(3000330) Specific gravity of Urine by Test strip

619

4569

1.38

12.39

4.5

3.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

328

2147

1.54

12.36

1.2

—

(3011412) CD3 cells [#/volume] in Blood

151

803

1.89

12.26

2.2

2.4

1.14

1.18

e9/l

0.29

130

729

(3000012) Reticulocyte production index

206

1205

1.72

12.20

3.1

2.0

—

(3014271) Vancomycin [Susceptibility]

415

2.25

12.11

3.6

2.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1312

10757

1.25

12.10

4.5

31.82

32.40

1.23

987

7349

(3000492) Spirometry study

1052

8407

1.28

12.05

1.6

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

262

1638

1.61

12.04

1.4

1.2

—

(3051651) Icteric interference index of Serum or Plasma

110

528

2.09

11.94

4.2

3.5

—

(3045414) Leukocytes [Presence] in Urine

546

3973

1.39

11.92

2.2

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

158

861

1.85

11.90

2.5

2.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

342

2279

1.52

11.88

1.2

144.69

158.05

titre

0.10

190

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

128

651

1.98

11.87

1.3

1.2

20.18

5.88

u/ml

0.35

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1700

14355

1.22

11.86

1.6

1.5

—

(4062490) Immunoglobulin typing, IgG

157

856

1.85

11.81

1.4

—

(3011648) Oxygen content in Venous blood

131

674

1.96

11.75

2.6

2.3

10.60

11.10

0.76

131

674

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2185

18911

1.20

11.74

1.7

46218450.71

30684788.19

pmol/l

0.41

1798

15679

(21494815) CD4 cells/100 lymphocytes in Specimen

132

684

1.94

11.60

2.0

2.2

37.81

39.00

0.32

127

677

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

903

7112

1.29

11.58

3.8

2.6

61.16

65.69

ml/min/173m2

2.71

418

2807

(3003434) Protein [Mass/volume] in Pleural fluid

194

1137

1.72

11.44

1.4

1.5

34.07

32.76

g/l

0.67

176

1014

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

125

642

1.96

11.29

1.9

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

278

1792

1.57

11.25

1.3

38.99

48.62

u/ml

0.53

180

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

705

5390

1.33

11.23

1.3

43.44

56.73

au/ml

0.71

313

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

128

665

1.94

11.18

1.3

1.2

252.50

164.67

titre

0.49

107

(3051611) Lipemic interference index of Serum or Plasma

163

915

1.79

11.18

3.8

3.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

347

2351

1.49

11.16

2.2

2.0

11.94

11.34

mg/l

0.54

329

2191

(3004616) Nuclear Ab [Presence] in Serum

181

1050

1.74

11.09

1.3

—

(3007463) Buprenorphine [Presence] in Urine

13.87

10.94

5.3

5.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

683

5218

1.33

10.94

1.4

1.3

181.77

226.55

u/ml

1.14

629

4815

(3011288) Drugs identified in Urine by Screen method

262

1678

1.58

10.92

11.1

2.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

127

665

1.92

10.86

1.3

1.2

98.75

207.14

titre

—

(3034770) Mitochondria Ab [Titer] in Serum

334

2259

1.49

10.84

1.2

975.00

896.10

titre

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

148

815

1.83

10.82

1.2

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

154

860

1.80

10.76

1.4

5.78

6.64

g/l

2.87

105

613

(3028192) IgG subclass 2 [Mass/volume] in Serum

154

860

1.80

10.76

1.4

2.68

2.90

g/l

0.81

104

614

(3024139) IgG subclass 3 [Mass/volume] in Serum

154

860

1.80

10.76

1.4

0.29

0.41

g/l

7.62

105

613

(3003694) ABO and Rh group [Type] in Blood

2683

23778

1.17

10.75

1.5

1.4

—

(3012441) Differential panel - Pleural fluid

156

877

1.79

10.67

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

145

798

1.83

10.63

3.5

2.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

216

1331

1.64

10.58

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

548

4083

1.36

10.38

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

217

1346

1.62

10.36

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

114

587

1.95

10.27

2.3

2.7

630.31

681.05

e6/l

0.48

106

568

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

248

1597

1.57

10.13

1.9

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

117

611

1.92

10.12

1.7

1.4

13.21

12.65

u/l

0.27

107

590

(3009508) Creatinine [Moles/volume] in Urine

3070

27601

1.16

10.08

3.9

3.1

7.29

7.54

mmol/l

2.33

2574

23198

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8846

85641

1.19

10.05

5.0

4.5

5.95

mmol/l

0.08

8100

78078

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

615

4688

1.33

10.01

2.6

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1219

10120

1.23

9.95

2.1

1.7

1.50

1.45

1.42

1040

8861

(3039162) Centromere protein B Ab [Units/volume] in Serum

181

1085

1.68

9.89

1.4

1.3

89.42

59.67

u/ml

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

151

2.92

9.88

1.3

108.13

107.33

0.05

144

(3033705) Calcium.ionized [Moles/volume] in Venous blood

187

1132

1.66

9.85

3.3

2.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

329

2.26

9.80

1.9

1.5

4324200.00

1163022.00

iu/ml

—

(3042631) Mycobacterium sp identified in Specimen

189

1149

1.66

9.79

2.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

108

557

1.95

9.71

2.2

2.5

549.95

503.60

e6/l

0.37

475

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

105

538

1.96

9.62

2.3

2.6

0.23

0.22

e9/l

0.22

474

(3023419) Bacteria identified in Sputum by Culture

203

1266

1.62

9.52

2.6

2.3

—

(4281824) Cell count and differential, peritoneal fluid

165

977

1.70

9.46

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

138

777

1.79

9.44

1.3

531.95

395.54

u/l

0.42

125

732

(3016750) Collection duration of Urine

494

1.99

9.42

2.6

2.2

486.20

497.25

min

0.49

377

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

191

1180

1.63

9.31

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

231

2.48

9.31

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

178

1084

1.65

9.19

1.2

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

112

598

1.88

9.11

1.3

13.07

13.03

u/l

0.01

100

558

(3020876) Protein [Mass/time] in 24 hour Urine

161

958

1.69

9.09

3.4

2.5

1.15

1.29

g/24h

0.28

473

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

124

686

1.82

9.02

1.1

—

(3012516) Albumin [Mass/volume] in Urine

2896

26102

1.15

8.97

3.6

3.2

662.52

411.32

mg/l

1.47

1883

16459

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

266

2.34

8.96

2.7

1.9

192.66

170.43

0.86

245

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

395

2.08

8.94

3.0

3.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

168

1018

1.66

8.86

1.5

2656.43

3179.69

e6/l

0.23

120

735

(3028707) Methadone [Presence] in Urine by Screen method

182

1127

1.63

8.82

8.4

2.3

—

(3019150) Specific gravity of Urine by Refractometry

2134

18830

1.17

8.79

5.1

4.1

1.02

kg/l

1.97

333

2822

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

599

1.86

8.75

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3034

27487

1.14

8.67

4.2

3.8

12.56

8.88

mg/mmol

2.90

1925

17248

(3019977) pH of Arterial blood

468

1.97

8.65

2.9

2.7

7.42

0.06

159

(3043409) Potassium [Moles/volume] in Arterial blood

360

2582

1.41

8.65

4.2

3.87

3.88

mmol/l

0.15

353

2555

(3036180) Methadone [Presence] in Urine

315

2.20

8.63

6.3

1.6

—

(40768806) Pleura Pathology biopsy report

152

904

1.69

8.62

1.5

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.51

8.50

2.0

—

(3010503) CD19 cells [#/volume] in Blood

514

1.91

8.44

2.3

2.6

0.12

0.43

e9/l

1.29

500

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

213

1386

1.55

8.39

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

243

2.35

8.38

1.4

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

105

565

1.87

8.37

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

192

1222

1.58

8.33

5.7

4.9

360.30

368.00

umol/l

0.21

158

1046

(1175426) CD3 cells/100 lymphocytes in Blood

116

647

1.80

8.25

2.1

2.0

70.99

72.36

0.42

110

618

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

362

2.08

8.17

2.8

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

161

988

1.64

8.13

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

383

2.04

8.12

1.2

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

687

5469

1.27

8.12

3.1

3.3

4.34

4.46

pmol/l

2.67

619

4841

(3001964) Herpes simplex virus Ag [Presence] in Specimen

247

2.31

8.09

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

329

2354

1.41

8.04

2.1

5304.12

4666.81

u/l

0.15

123

930

(3045788) Cell count panel - Pleural fluid

133

781

1.71

7.94

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

152

926

1.65

7.91

1.4

1.5

72307.35

61615.69

e6/l

0.15

550

(3023511) Choriogonadotropin [Units/volume] in Urine

181

1152

1.58

7.88

1.5

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

183

1168

1.58

7.87

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

132

777

1.71

7.82

1.3

1.4

6.12

6.37

mmol/l

0.43

124

709

(3047181) Lactate [Moles/volume] in Blood

378

2783

1.37

7.80

6.6

6.0

1.32

1.33

mmol/l

0.07

336

2456

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

203

1335

1.53

7.66

1.6

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

152

2.64

7.52

1.3

1.2

93.80

71.26

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

169

1071

1.59

7.52

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.01

7.33

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

218

1470

1.49

7.33

1.5

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

321

2329

1.39

7.27

3.0

2.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

367

2.00

7.18

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

367

2.00

7.18

1.4

1.5

—

(3004451) EKG impression Narrative

402

1.95

7.15

1.5

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.93

7.15

3.4

2.6

—

(3004775) Volume in Urine collected for unspecified duration

119

699

1.71

7.14

2.5

2.3

676.99

647.64

0.31

478

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

118

692

1.71

7.13

2.8

1.9

3.92

4.05

mg/l

0.12

109

656

(40768441) Liver Pathology biopsy report

105

596

1.77

7.11

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.34

7.09

2.0

2.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2953

26990

1.13

7.08

5.0

4.9

4.04

2.95

ug/l

0.66

2644

24276

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

902

7521

1.22

7.03

2.0

1.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

475

1.86

7.02

3.0

2.8

34.48

39.36

1.40

282

(36660697) Celiac disease serology panel - Serum

799

6582

1.23

7.01

1.2

1.1

—

(3020891) Body temperature

447

3432

1.32

7.01

4.9

4.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

426

1.91

7.00

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

426

1.91

7.00

1.5

1.4

—

(4200892) Spirometry reversibility

772

6338

1.23

7.00

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

152

2.57

6.99

1.6

1.1

98.00

73.49

2.23

(3017446) Testosterone [Moles/volume] in Serum or Plasma

723

5896

1.24

6.97

2.3

2.1

11.60

12.67

nmol/l

3.09

627

5274

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8613

83748

1.14

6.95

4.2

3.9

1.34

1.31

mmol/l

3.50

7884

76554

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

817

6757

1.23

6.90

1.9

1.8

—

(3022621) pH of Urine by Test strip

718

5859

1.24

6.89

3.3

3.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

573

1.77

6.87

1.5

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

129

784

1.65

6.84

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.25

6.81

1.1

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

160

1030

1.56

6.70

1.5

51.69

58.23

1.30

110

648

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

440

1.87

6.69

1.6

1.8

1.81

2.23

u/field

0.39

309

(1001926) Buprenorphine [Presence] in Urine by Screen method

275

1974

1.40

6.67

6.3

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

243

1707

1.43

6.66

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

289

2.08

6.65

1.7

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

378

2857

1.33

6.64

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

137

853

1.61

6.61

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

186

1245

1.50

6.53

1.1

4.83

12.83

au/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

560

1.76

6.52

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

738

6082

1.23

6.47

1.7

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

518

1.78

6.45

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

228

2.20

6.38

2.2

1.9

21.78

39.97

u/l

0.88

210

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

520

1.78

6.37

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

142

2.54

6.33

1.2

1.5

32.00

27.03

g/l

0.79

110

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

286

2088

1.38

6.30

1.3

504.87

525.76

mg/l

0.32

273

1987

(21494755) Public health laboratory ask at order entry panel

667

8103

0.81

6.26

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

186

2.32

6.22

5.5

65.44

71.04

0.82

143

(3035880) pH of Pleural fluid

444

1.83

6.21

1.2

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

424

1.85

6.15

1.7

1.4

19.93

25.45

umol/l

1.01

403

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

184

2667

0.68

6.07

1.4

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

220

2.19

6.07

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

272

1987

1.38

5.99

1.4

223.70

155.28

pmol/l

0.69

261

1931

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.34

5.98

1.1

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.87

5.97

4.9

4.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.00

5.89

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

172

2.33

5.88

1.3

16.64

13.77

g/l

0.90

133

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8934

87308

1.14

5.83

4.7

4.4

4.63

4.69

mmol/l

5.58

8264

80881

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

115

711

1.62

5.77

1.9

2.1

1.74

2.10

u/field

0.35

262

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8871

86670

1.14

5.74

4.6

4.4

1.43

1.47

mmol/l

18.46

8160

79875

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

252

1832

1.38

5.73

1.2

3.75

3.80

mmol/l

0.39

231

1730

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

456

1.78

5.73

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

575

1.69

5.72

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

161

1082

1.50

5.61

2.4

2.0

24.77

24.14

mg/l

0.05

274

(3044242) Glucose [Moles/volume] in Arterial blood

409

1.81

5.57

2.6

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

137

892

1.54

5.54

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

439

1.78

5.53

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

367

1.86

5.52

2.0

181.80

138.57

umol/l

0.31

195

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

200

1407

1.43

5.51

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

165

2.31

5.49

1.4

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

326

1.91

5.46

1.3

1.2

—

(40768793) Breast Pathology biopsy report

277

2063

1.35

5.44

1.3

—

(40761535) Cells panel - Urine sediment

852

7243

1.19

5.44

4.5

3.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

122

778

1.57

5.41

1.6

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

249

1833

1.37

5.28

1.6

1.4

1000.90

1129.37

e6/l

0.10

202

1493

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

145

967

1.51

5.27

1.2

58.23

63.51

u/l

0.49

131

861

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

124

800

1.56

5.25

3.7

3.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

215

2.10

5.18

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

309

2360

1.32

5.14

6.1

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

296

2248

1.33

5.12

1.1

2.80

8.31

u/ml

2.06

280

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.84

5.07

3.0

3.4

1.14

1.09

mg/l

0.05

(3012565) Volume of 24 hour Urine

444

1.74

5.07

2.6

2.2

1856.25

1953.42

0.37

394

(1617658) Protocol used for examination of sentinel lymph nodes

110

697

1.58

5.05

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

247

1832

1.36

5.02

1.5

1.4

41.73

35.05

e6/l

0.10

190

1409

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

498

1.69

5.01

1.7

1.3

—

(3047189) Immunofixation for 24 hour Urine

387

1.79

4.99

1.9

1.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.96

4.97

2.5

1.5

51.57

42.44

umol/l

1.03

(3016018) Differential panel - Cerebral spinal fluid

133

887

1.51

4.87

1.7

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

413

1.75

4.84

1.4

1.2

69.86

63.78

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

595

1.62

4.84

2.7

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

201

2.09

4.84

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

107

2.53

4.78

2.2

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.72

4.74

3.1

3.6

—

(40757373) Influenza virus identified in Isolate

157

2.23

4.73

1.7

1.6

—

(3039000) Anion gap in Blood

259

1956

1.33

4.70

7.9

7.1

11.36

11.31

mmol/l

0.10

228

1751

(3042010) Triglyceride [Moles/volume] in Pleural fluid

108

2.50

4.69

1.4

1.2

1.00

1.71

mmol/l

0.46

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

141

960

1.47

4.68

1.2

1.1

—

1.55

—

(3018572) Chloride [Moles/volume] in Blood

259

1957

1.33

4.68

7.9

7.1

105.44

105.20

mmol/l

0.35

228

1752

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9073

88997

1.13

4.66

5.1

4.9

2.75

2.78

mmol/l

1.58

8352

82076

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

127

2.37

4.63

1.2

1.3

39.31

110.66

ng/l

1.63

(3006245) CD3-CD19+ cells/100 cells in Blood

302

1.86

4.62

2.0

2.1

11.38

10.34

0.21

280

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

134

908

1.48

4.57

1.9

1.8

3108.57

1400.00

titre

—

(3000764) Benzodiazepines [Presence] in Urine

324

2535

1.29

4.55

5.9

1.8

—

(3027944) Amphetamines [Presence] in Urine

321

2509

1.29

4.54

5.5

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

152

1057

1.44

4.54

1.1

1.53

1.51

g/l

0.33

142

949

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

227

1.99

4.53

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

141

2.27

4.52

1.3

1.4

—

(3028300) Cannabinoids [Presence] in Urine

326

2558

1.28

4.48

5.9

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

161

2.18

4.47

1.9

2.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

592

1.59

4.47

1.4

1.3

1.99

1.52

u/ml

0.21

333

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

242

1.95

4.47

1.2

—

(3045424) Erythrocytes [Presence] in Urine

202

1481

1.37

4.46

1.6

1.5

—

(40768795) Lymph node Pathology biopsy report

128

864

1.49

4.46

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

400

3221

1.25

4.44

1.6

1.7

—

(3027008) Opiates [Presence] in Urine

325

2553

1.28

4.43

5.2

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

250

1.92

4.42

1.3

4.08

3.33

mmol/l

0.73

226

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

251

1.92

4.37

2.6

3.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.56

4.37

1.2

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

228

1710

1.34

4.36

2.5

1.8

0.95

0.80

nmol/l

2.09

202

1428

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

217

1.99

4.34

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

115

765

1.51

4.31

1.4

1.5

34.74

29.62

0.71

459

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

274

1.87

4.29

1.5

1.2

22.17

24.33

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

132

2.28

4.27

1.6

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

171

2.11

4.27

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

100

647

1.55

4.26

1.2

1.3

2.31

2.05

mmol/l

0.99

611

(1761482) Bacteria [#/volume] in Urine by Culture

304

2384

1.28

4.22

5.6

4.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

3.26

4.18

1.1

1.3

280.47

2201.34

u/l

0.64

(3010144) Erythrocytes [#/volume] in Synovial fluid

118

795

1.49

4.17

1.4

243418.89

156987.14

e6/l

0.47

547

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

540

1.60

4.17

1.2

107.16

82.87

u/l

1.88

463

(3017704) Immunofixation for Urine

440

1.66

4.16

2.3

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

115

2.35

4.14

1.4

7.44

382836.95

nmol/l

1.08

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.24

4.13

1.2

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

344

1.75

4.10

2.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

576

1.57

4.04

1.5

85.94

81.39

umol/l

0.33

576

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

526

1.58

3.90

1.2

31.17

21.93

u/l

1.10

438

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

263

1.83

3.84

2.2

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

263

1.83

3.84

2.2

2.7

—

(3032057) Clostridioides difficile [Presence] in Stool

187

1.98

3.76

2.1

1.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

484

1.60

3.76

12.7

12.2

0.60

0.63

mmol/l

0.71

439

(3000060) B lymphocytes [#/volume] in Blood

215

1.91

3.75

1.7

2.0

157.78

558.60

e6/l

0.71

121

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

627

1.52

3.75

1.7

1.5

21.19

23.06

u/ml

0.23

141

(3034274) Bile acid [Moles/volume] in Serum --fasting

111

758

1.47

3.72

2.1

2.0

6.73

7.22

umol/l

0.10

545

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

288

1.77

3.71

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

541

1.56

3.70

1.3

420.00

360.00

titre

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.00

3.68

1.2

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1700

15572

1.11

3.67

3.0

0.80

0.77

ug/l

0.49

1179

10308

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

341

1.70

3.67

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

135

2.15

3.66

1.1

—

(3044927) Protein electrophoresis panel - Urine

119

827

1.44

3.65

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

662

7647

0.86

3.62

1.8

1.7

—

(3033799) Differential panel - Peritoneal fluid

218

1.88

3.61

2.1

1.8

—

(3024263) Appearance of Synovial fluid

443

1.61

3.59

1.3

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

163

2.03

3.58

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

284

1.76

3.58

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

660

5700

1.17

3.58

1.2

119.29

148.88

iu/ml

1.31

217

2143

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.44

3.54

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

263

1.79

3.54

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

414

1.62

3.53

3.6

3.7

—

(40758292) HTLV I+II Ab panel - Serum

124

2.18

3.53

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

399

1.63

3.52

3.1

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

101

686

1.48

3.50

1.2

1.3

—

titre

—

(3024869) Neuronal Ab [Presence] in Serum

172

1.98

3.47

1.0

1.1

—

(3048879) Bone marrow aspiration report

244

1.81

3.42

1.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.66

3.39

7.9

10.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.57

3.37

1.1

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.57

3.37

1.2

1.3

46.49

122.98

ug/l

—

(3044007) Cell count panel - Peritoneal fluid

195

1.90

3.37

1.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.00

3.36

1.2

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

525

1.53

3.29

2.0

1.4

4.89

6.25

u/l

2.15

439

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

103

712

1.45

3.29

1.3

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.64

3.28

1.0

0.02

0.08

u/ml

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

8.58

3.26

1.2

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

431

1.58

3.26

1.5

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

408

1.60

3.24

12.2

10.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

238

1884

1.27

3.17

4.4

3.5

30.15

27.86

mg/l

0.36

160

1172

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

222

1.80

3.13

1.2

1.3

89.32

121.81

nmol/l

1.12

163

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.54

3.12

2.0

2.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

180

1.89

3.08

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

288

2339

1.24

3.08

1.3

186.96

224.82

miu/ml

0.99

105

1073

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.58

3.03

1.1

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

240

1.75

3.00

1.8

449.90

4299.92

e6/l

0.61

163

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

211

1.80

2.98

1.6

4338.18

9998.36

e6/l

1.04

110

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

100

2.20

2.98

1.5

1.2

1527.53

113.33

u/l

0.47

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

275

2231

1.24

2.98

1.8

40.35

41.53

nmol/l

0.39

264

2159

(3050794) Legionella sp Ab [Presence] in Serum

2.40

2.96

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.24

2.95

1.3

1.4

69.69

79.51

0.68

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

198

1.82

2.92

1.3

1.1

—

(3014891) Appearance of Pleural fluid

121

2.07

2.91

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

203

1597

1.28

2.88

2.1

1.9

189.93

200.59

pmol/l

0.72

194

1497

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.71

2.87

1.8

1.9

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

617

1.45

2.85

1.1

1.0

297.95

289.60

mg/l

0.53

556

(3006576) Bicarbonate [Moles/volume] in Blood

297

1.65

2.85

5.1

6.7

25.04

24.88

mmol/l

0.11

270

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

136

1.99

2.84

3.5

2.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

252

1.71

2.83

1.2

41.33

38.76

g/l

0.45

138

(3026389) Candida sp identified in Specimen by Organism specific culture

172

1328

1.30

2.83

1.3

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2463

23208

1.08

2.80

1.7

1.6

1.42

1.39

mmol/l

1.39

2089

19453

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

485

4176

1.17

2.80

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

156

1193

1.31

2.76

1.3

1.4

0.30

0.38

nmol/l

0.94

101

911

(3008898) HLA-B27 [Presence]

337

2817

1.20

2.75

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

140

1055

1.33

2.74

1.4

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

524

1.47

2.73

1.4

1.3

76.00

64.09

titre

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

657

1.42

2.71

1.3

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

341

1.59

2.69

3.3

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

663

5865

1.14

2.65

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

453

3902

1.17

2.63

1.4

1.3

29.14

31.33

iu/l

0.69

383

3389

(3020961) Endomysium IgA Ab [Titer] in Serum

455

3921

1.17

2.62

1.1

140.00

211.64

titre

—

104

(1002224) Polysomnography panel

411

3513

1.18

2.62

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

391

1.54

2.62

1.3

1.5

6.78

4.14

0.28

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

169

1.84

2.62

1.4

1.5

87.19

119.49

ng/l

1.31

169

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.46

2.61

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

257

2108

1.22

2.57

1.5

1.3

11.89

11.13

u/l

0.32

206

1735

(3006270) Folate [Moles/volume] in Blood

108

793

1.37

2.54

1.2

336.84

355.87

nmol/l

0.28

664

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

2.52

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

469

1.47

2.49

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

585

1.42

2.48

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.38

2.45

8.3

6.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.46

2.44

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

571

1.42

2.43

1.8

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

396

3401

1.17

2.41

1.1

24.32

8.01

u/ml

0.29

(3035320) C reactive protein [Mass/volume] in Body fluid

614

1.40

2.40

3.1

2.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

110

2.00

2.40

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

201

1621

1.24

2.38

1.9

1.8

5.02

5.00

mmol/24h

0.02

176

1434

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

297

1.59

2.37

1.4

1.2

0.33

0.30

g/l

1.22

239

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

150

1168

1.29

2.37

1.0

1.1

2.66

3.32

u/ml

0.39

557

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.42

2.36

1.6

1.5

3.58

3.99

mg/l

0.11

(3009015) Lactate [Moles/volume] in Synovial fluid

2.06

2.36

1.1

1.2

9.90

6.08

mmol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

146

1.85

2.36

3.8

2.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

111

1.98

2.35

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

119

900

1.33

2.33

1.6

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

155

1.81

2.29

1.2

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

372

1.51

2.28

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.22

2.27

1.1

1.0

0.05

0.16

u/ml

0.56

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.55

2.26

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.07

2.26

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

309

1.56

2.26

7.7

1.8

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

149

1.81

2.23

3.1

2.5

131.76

128.10

ng/l

0.02

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

161

1278

1.26

2.21

1.2

1.3

0.16

0.22

nmol/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

445

5083

0.87

2.20

1.5

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

2.50

2.18

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

584

1.39

2.17

1.7

1.5

4.81

7.73

u/l

1.83

470

(40757494) Bilirubin.total [Moles/volume] in Blood

485

1.43

2.14

2.1

2.3

13.60

26.82

umol/l

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

478

1.43

2.11

1.2

1.1

90.10

85.25

u/l

0.15

431

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.05

2.10

2.6

2.5

0.39

0.93

mmol/l

1.44

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.21

2.10

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.45

2.10

1.4

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

102

1.96

2.09

1.1

1.0

0.01

0.41

u/ml

0.86

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.14

2.08

6.3

2.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

206

1.65

2.06

1.3

1.2

53.08

38.12

1.58

140

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

110

1.91

2.05

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

146

1159

1.26

2.03

1.2

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

254

1.58

2.02

1.4

1.3

61.45

55.09

0.51

212

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

177

1.70

2.01

2.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

193

1.66

1.99

1.0

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

159

1280

1.25

1.97

1.2

1.3

0.59

2.64

nmol/l

1.00

153

1238

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

248

1.57

1.97

1.1

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.08

1.96

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

639

1.35

1.95

1.2

41.08

41.46

mg/l

0.02

536

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

257

1.56

1.94

2.8

3.0

6.16

7.97

mg/l

1.34

207

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.24

1.90

1.2

1.1

1.17

1.21

ml/s/173m2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

150

1.74

1.90

1.3

1.2

2.51

1.75

mmol/l

1.00

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

189

1.64

1.86

1.8

1.5

0.51

0.38

ug/l

0.45

120

(3026726) Creatinine [Moles/volume] in Specimen

2.08

1.86

3.3

2.4

288.27

489.91

umol/l

0.35

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.39

1.85

1.0

1.1

8.46

8.35

mmol/l

0.10

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

3.53

1.83

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

110

859

1.28

1.79

1.1

—

91.74

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

303

1.49

1.79

3.2

2.4

150.33

150.83

nmol/l

0.01

265

(3023410) Appearance of Cerebral spinal fluid

105

815

1.29

1.79

1.8

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

454

1.39

1.76

1.4

1.2

—

(3028433) Virus identified in Specimen by Culture

288

1.50

1.76

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

505

1.37

1.76

1.1

11.56

9.74

iu/ml

0.20

123

(3011985) Renin [Units/volume] in Plasma

149

1213

1.23

1.71

1.4

61.71

54.51

mu/l

0.20

134

1088

(3006567) Chloride [Moles/time] in 24 hour Urine

3.85

1.71

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.29

1.70

1.3

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

234

1.54

1.69

1.1

1.3

911.32

183.79

ug/l

0.60

127

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

612

1.33

1.69

1.1

248.71

267.10

mg/l

0.46

537

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

299

1.47

1.69

1.5

1.4

66.98

63.13

0.29

254

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2262

21604

1.06

1.69

4.3

4.2

21.79

21.85

0.06

1106

10553

(3020191) Ethanol [Moles/volume] in Serum or Plasma

648

1.31

1.67

1.6

1.4

1.43

1.32

promille

0.23

493

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

405

0.62

1.65

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.80

1.65

1.0

1.1

—

(4034850) Laboratory test

326

2854

1.15

1.64

8.6

9.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

529

1.34

1.64

1.1

7.90

6.27

nmol/l

0.12

108

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

252

2165

1.17

1.64

1.6

1.8

5.37

8.57

iu/l

0.37

791

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

150

1.67

1.62

2.7

2.0

12.15

16.94

umol/l

2.80

150

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.14

1.61

1.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

508

1.34

1.55

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

145

1.66

1.53

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

192

1.56

1.53

1.6

1.1

—

(46236302) HLA-C [Type] by High resolution typing

2.59

1.51

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

2.59

1.51

1.1

1.0

—

(40760409) HLA-A [Type] by High resolution

2.59

1.51

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

2.59

1.51

1.1

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.16

1.50

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

116

1.73

1.48

1.2

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

410

1.37

1.47

4.7

5.4

49.00

9116.37

u/ml

—

(3013862) HLA-DP [Type]

2.50

1.45

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.97

1.43

1.1

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

336

1.40

1.43

1.1

1863.23

227.90

ng/l

0.50

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

204

1.52

1.42

1.4

1.3

31.65

23.41

0.49

174

(1761868) Lipid panel - Serum or Plasma

3025

31268

0.95

1.40

3.0

2.8

—

(3003181) Sodium [Moles/volume] in Urine

176

1495

1.18

1.36

1.4

63.41

63.64

mmol/l

0.02

143

1189

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

109

884

1.24

1.36

1.1

—

13.18

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

442

1.34

1.36

2.0

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

240

1.46

1.34

2.3

2.4

280.15

141.39

au/ml

—

(3001019) Free T4 and TSH panel - Serum or Plasma

398

4413

0.90

1.33

1.6

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

136

1132

1.20

1.33

1.2

1.3

307.26

422.11

pmol/l

0.63

116

966

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.78

1.32

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

789

1.24

1.32

1.4

1.3

1.52

1.46

nmol/l

0.16

711

(3008295) Osmolality of Serum or Plasma

107

870

1.23

1.32

1.6

1.4

285.74

279.22

mosm/kgh2o

2.02

662

(3026470) Cobalt [Mass/volume] in Blood

523

1.30

1.32

1.8

1.9

3.53

3.29

ug/l

0.15

474

(3013293) Extractable nuclear Ab [Presence] in Serum

144

1.60

1.31

1.8

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

225

1.47

1.30

2.1

1.8

—

(3008607) Semen analysis panel

2.50

1.30

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

481

1.31

1.29

1.8

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.78

1.28

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

185

1.51

1.28

1.4

1.8

2.36

2.10

ug/l

0.20

(40762814) Titanium [Mass/volume] in Blood

145

1.59

1.28

2.3

2.2

2.81

4.14

ug/l

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

310

1.39

1.27

1.4

14.66

15.88

pmol/l

0.81

255

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

277

1.41

1.26

1.4

1.2

113.38

111.77

0.12

243

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.40

1.24

17.8

9.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.40

1.24

5.2

1.2

90.50

209.00

ug/l

—

(3028717) Thiamine [Mass/volume] in Blood

100

1.70

1.23

1.4

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.04

1.21

2.7

3.6

—

(3025577) Chromium [Mass/volume] in Blood

513

1.29

1.21

1.8

2.0

2.47

2.34

ug/l

0.12

435

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.72

1.21

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

221

1.45

1.20

1.3

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

124

1.61

1.20

1.2

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

546

0.73

1.18

1.3

1.51

1.56

g/l

0.52

546

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.11

1.18

11.6

6.9

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.11

1.18

1.1

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.88

1.17

2.0

1.8

1.45

1.36

umol/l

0.49

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

256

1.41

1.17

2.4

1.9

7.19

9.43

mg/l

2.08

205

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

198

1.47

1.16

1.2

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

282

1.38

1.15

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

158

1.52

1.14

1.0

1.1

2.98

5.27

pmol/l

—

(3012898) Urea [Moles/volume] in Urine

1.75

1.12

1.1

1.3

153.60

170.13

mmol/l

0.27

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.33

1.12

1.3

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

250

1.40

1.12

1.5

1.4

4.74

1.90

0.73

215

(3041672) Baker's yeast Ab [Presence] in Serum

2.00

1.12

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.00

1.12

1.0

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

243

2154

1.13

1.11

2.8

2.3

122.42

87.85

ug/min

0.53

155

1286

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.26

1.10

5.9

5.7

464.57

392.45

umol/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.38

1.09

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.95

1.08

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

218

1.42

1.08

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

218

1.42

1.08

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

218

1.42

1.08

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

218

1.42

1.08

1.0

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

152

1.51

1.08

1.1

1.0

6.65

7.73

mg/g

0.58

143

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

257

2874

0.89

1.06

2.2

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

211

1.42

1.05

7.8

7.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.71

1.05

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

449

4133

1.09

1.03

1.8

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.92

1.02

1.8

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

438

1.28

1.01

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

359

1.31

1.01

2.3

2.4

49.41

53.28

umol/l

0.38

305

(3033923) Metanephrine [Moles/time] in 24 hour Urine

188

1.44

1.01

1.0

1.1

0.63

0.65

umol/24h

—

(3020491) Glucose [Moles/volume] in Blood

655

1.22

0.99

1.8

1.9

6.58

6.74

mmol/l

0.27

454

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.84

0.98

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

476

1.26

0.98

1.3

1.4

1.49

1.21

nmol/l

0.71

374

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

278

3074

0.90

0.96

1.9

1.7

3.63

4.12

mg/l

0.54

227

2246

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.65

0.94

1.2

8.84

10.65

mg/l

0.35

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

760

1.20

0.94

1.6

1.3

2.57

4.20

ug/l

1.33

641

(3005011) Chlamydia sp Ab [Titer] in Serum

117

1.54

0.93

1.4

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.67

0.91

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

104

0.48

0.88

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

237

1.35

0.87

1.8

1.6

10.88

8.71

ug/l

1.09

237

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

169

1495

1.13

0.86

1.8

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

414

1.26

0.85

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

146

1282

1.14

0.83

1.4

1.3

26.96

29.35

u/l

0.40

121

1044

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

515

1.22

0.83

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

130

1.46

0.80

1.4

7.91

11.73

0.42

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.56

0.78

1.3

1.2

18.41

20.60

u/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

322

1.27

0.77

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

557

1.20

0.76

1.1

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

612

1.19

0.76

1.8

1.9

16.60

17.52

nmol/l

0.46

572

(3038071) Oxygen [Partial pressure] in Mixed venous blood

183

1.37

0.75

8.4

7.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

440

1.23

0.75

2.4

2.2

169.43

87.76

ug/min

0.31

(3027456) Digoxin [Moles/volume] in Serum or Plasma

180

1616

1.12

0.75

3.2

3.0

0.76

0.83

nmol/l

1.75

144

1233

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

227

1.32

0.74

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

201

1.34

0.74

2.1

1.7

163.76

92.20

au/ml

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.64

0.73

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

167

1.38

0.73

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.67

0.72

2.7

4.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.75

0.71

1.0

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

553

1.19

0.71

1.1

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.92

0.70

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

118

1.44

0.69

1.1

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

110

1.46

0.68

13.5

8.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

231

1.30

0.67

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

338

1.24

0.67

1.6

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

170

1.35

0.67

4.1

6.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

595

1.18

0.66

1.5

1.4

335.94

166.27

pmol/l

0.69

595

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

232

1.29

0.65

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

120

1.42

0.64

1.3

1.2

—

75.39

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.72

0.64

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.59

0.61

2.6

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.67

0.61

1.4

453.38

490.95

nmol/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.67

0.61

1.2

—

(3051339) Copper [Moles/volume] in Blood

1.60

0.61

1.0

1.1

18.83

17.08

umol/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

817

1.14

0.59

4.0

4.9

140.89

120.01

u/ml

0.12

244

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.58

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.51

0.58

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

115

1.39

0.56

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.62

0.55

1.2

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

131

1182

1.11

0.55

1.4

1.2

6.81

7.41

mmol/l

2.00

116

1049

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

302

1.23

0.55

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

230

1.26

0.55

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

330

1.21

0.54

1.7

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

143

1573

0.91

0.54

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

908

0.88

0.52

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

158

0.70

0.52

1.9

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

1.43

0.52

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

770

1.13

0.51

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.47

0.50

3.3

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

370

1.19

0.50

1.1

1411.00

1446.09

miu/ml

0.10

370

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

119

1.35

0.48

1.1

1.2

—

(4146454) Self-monitoring of blood glucose

105

946

1.11

0.48

2.3

2.7

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

208

1.25

0.47

1.0

14.36

10.76

u/ml

0.20

117

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1068

11001

0.97

0.47

9.1

6.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

102

1.37

0.47

1.1

—

(3016038) Potassium [Moles/volume] in Urine

551

1.14

0.46

1.2

40.24

34.97

mmol/l

0.71

456

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.43

0.45

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

394

1.17

0.44

1.3

1.2

145.65

160.71

mmol/24h

0.87

394

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

376

1.17

0.44

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

104

1.35

0.43

2.6

0.64

0.57

u/field

0.10

104

(3021387) Prolactin [Units/volume] in Serum or Plasma

269

2538

1.06

0.42

1.7

310.80

296.25

mu/l

0.28

241

2300

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.43

0.42

1.0

0.02

0.13

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1398

13658

1.03

0.42

1.5

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

203

1.23

0.42

1.1

1.62

1.05

u/ml

0.32

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

185

1.24

0.41

2.7

2.3

8.28

8.07

mmol/l

0.10

112

(3022475) Manganese [Moles/volume] in Blood

1.38

0.41

1.5

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.52

0.41

1.0

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

341

3244

1.05

0.41

1.8

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

105

1.33

0.41

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.36

0.41

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

145

1342

1.08

0.40

1.1

57.22

7921.82

iu/ml

0.57

311

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.47

0.40

1.2

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

443

0.86

0.39

1.1

1.0

1.10

0.81

u/ml

0.32

100

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

214

1.22

0.39

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.41

0.39

2.6

2.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

106

1.32

0.39

1.9

1.8

8.20

7.45

mmol/l

—

(4212803) Bone marrow aspirate examination

1.38

0.38

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

562

1.12

0.37

5.5

6.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

396

1.14

0.33

1.1

6.37

6.83

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

128

1191

1.08

0.33

1.1

1.22

1.44

u/ml

0.20

565

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.30

0.33

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

173

1.21

0.32

1.3

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.35

0.32

3.3

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

111

1031

1.08

0.31

1.1

1.0

4.43

3.33

u/ml

0.30

455

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.35

0.31

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

983

9616

1.02

0.30

1.6

—

(3025130) Human papilloma virus identified in Specimen

118

1102

1.07

0.29

1.6

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

920

1.08

0.28

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

597

0.90

0.28

1.0

35.74

42.82

ng/l

0.85

417

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

595

0.91

0.27

1.0

810.61

719.85

ng/l

0.76

412

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

594

0.91

0.26

1.0

281.33

322.20

ng/l

0.75

425

(3003338) MCHC [Mass/volume]

7512

74816

1.01

0.26

29.4

17.8

330.62

332.29

g/l

46.39

7450

74246

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

105

1.24

0.24

1.4

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.17

0.24

1.3

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

190

0.84

0.23

1.1

1.3

15.36

76.59

mu/l

—

141

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.32

0.23

1.2

1.4

43.82

18.58

nmol/l

—

(40758358) Immune stain study

1.32

0.23

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

332

1.11

0.23

3.5

3.0

26.86

28.24

umol/l

0.45

247

(40768800) Prostate Pathology biopsy report

179

1712

1.05

0.23

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.28

0.23

1.0

1.1

319.60

248.98

nmol/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.74

0.22

1.3

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.2

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

0.20

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.16

0.21

1.2

1.0

0.03

3.58

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

126

1.19

0.21

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

162

1691

0.96

0.20

1.5

1.4

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.04

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.25

0.20

1.0

1.1

—

4.79

u/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

114

0.79

0.20

2.3

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

114

0.79

0.20

4.7

6.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

127

1.18

0.19

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

394

1.09

0.19

1.0

0.61

1.06

u/ml

0.21

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.15

0.19

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

447

0.92

0.19

1.1

0.59

0.99

u/ml

0.32

142

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

103

1084

0.95

0.18

1.8

1.7

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.19

0.18

6.0

2.8

48.80

47.57

g/mol

—

(3000285) Sodium [Moles/volume] in Blood

110

1.18

0.17

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.11

0.16

2.4

2.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

206

1.12

0.16

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

122

1268

0.96

0.14

1.1

0.55

1.20

u/ml

0.96

511

(3020911) Cortisol [Moles/time] in 24 hour Urine

294

1.09

0.14

1.4

84.24

177.77

nmol/24h

1.29

294

(3000034) Microalbumin [Mass/volume] in Urine

860

0.95

0.14

3.0

2.9

47.83

52.61

mg/l

0.09

636

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.18

0.14

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.18

0.14

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

138

1332

1.04

0.14

1.1

3.92

4.84

u/ml

0.30

648

(3045683) HLA typing for celiac disease panel - Blood or Tissue

490

1.06

0.13

1.1

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

844

1.04

0.12

1.1

1.0

0.61

0.55

u/ml

0.04

224

(3043238) Trisomy 21 risk [Likelihood] in Fetus

113

1171

0.96

0.12

1.5

—

(3005033) Fetal Nuchal fold Thickness US

109

1130

0.96

0.12

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

104

1.15

0.12

3.0

2.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

443

1.06

0.12

1.0

1.1

1.04

1.08

u/l

0.33

206

(3015183) Erythrocyte sedimentation rate

404

1.06

0.12

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

151

1466

1.03

0.12

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

116

0.86

0.12

1.2

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.16

0.11

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

143

1.12

0.11

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

143

1.12

0.11

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

143

1.12

0.11

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

219

0.91

0.11

1.5

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

240

2450

0.98

0.11

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.16

0.11

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

397

1.06

0.10

1.6

1.7

3.69

4.66

nmol/l

0.18

331

(3006462) Nitrate [Presence] in Urine

433

0.95

0.10

3.6

3.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

1.13

0.09

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

110

1132

0.97

0.09

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

155

0.90

0.09

6.0

7.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

248

2523

0.98

0.09

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

339

0.94

0.08

2.4

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

151

1477

1.02

0.08

1.3

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.83

0.08

1.4

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

756

7496

1.01

0.08

1.4

—

(3022689) Creatine [Moles/volume] in Urine

273

1.06

0.08

2.0

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.14

0.08

1.0

1.2

1.61

1.66

umol/24h

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.06

0.08

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.03

0.07

1.1

—

(3001729) Color of Synovial fluid

1.08

0.07

1.0

1.5

—

(44813793) Dust mix specific IgE antibody measurement

591

0.96

0.07

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.07

0.07

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

550

1.04

0.07

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.82

0.07

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

295

2916

1.01

0.06

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

212

0.94

0.05

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

110

0.91

0.05

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

238

1.05

0.05

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

139

1376

1.01

0.02

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

124

1253

0.99

0.02

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

139

1377

1.01

0.02

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

182

1.04

0.02

1.4

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

124

1252

0.99

0.02

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

138

1372

1.01

0.01

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

966

0.99

0.00

1.1

1.0

2.45

3.74

u/ml

0.61

370

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

336

1.01

0.00

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

124

1243

1.00

0.00

1.6

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

138

1377

1.00

0.00

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

147

1465

1.00

0.00

1.1

1.69

1.92

u/ml

0.12

701

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

129

1.01

0.00

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.85

0.00

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

2.86

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

66.12

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.94

-0.00

1.0

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

2.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.97

-0.00

1.0

1.1

10.67

14.73

u/l

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

303.50

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

-0.00

0.0

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.2

—

40.14

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

7.72

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

15.60

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_PHLETHROM and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_PHLETHROM	1.834 [1.67, 2.01]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.177

During the follow-up period (1.1.1998 — 31.12.2019), 9742 out of 34842 females with I9_PHLETHROM died.

Males

Parameter	HR [95% CI]	p-value
I9_PHLETHROM	1.749 [1.58, 1.94]	< 0.001
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 6754 out of 23525 males with I9_PHLETHROM died.

Mortality risk

Mortality risk for people of age

years, who have I9_PHLETHROM.

N-year risk	Females	Males
1	0.167%	0.274%
5	1.093%	1.634%
10	2.694%	4.257%
15	5.047%	8.003%
20	8.804%	13.049%

Relationships between endpoints

↥

Index endpoint: I9_PHLETHROM – Phlebitis and thrombophlebitis (not including DVT)

GWS hits: 23

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Phlebitis and thrombophlebitis (not including DVT)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints